| 1 | D (migalastat) | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 2 | D Mannose | [1] Mannose Mannose | [1] Demannose
Demannose
💬
| - | - | [1] 13 13 💬
|
| 3 | D-2570 | - | - | - | - | [2] 49 49, 97 💬
|
| 4 | D-a-tocopheryl PEG 1000 succinate | - | - | - | - | [1] 299 299 💬
|
| 5 | D-aspartate | - | - | - | - | [1] 13 13 💬
|
| 6 | D-BIOTIN | [1] Biotin Biotin | [1] Biotin
Biotin
💬
| - | - | [4] 10 10, 13, 14, 20 💬
|
| 7 | D-BIOTINA | [1] Biotin Biotin | [1] Biotin
Biotin
💬
| - | - | [1] 13 13 💬
|
| 8 | D-CURA | - | - | - | - | [1] 96 96 💬
|
| 9 | D-Cure | - | - | - | - | [1] 228 228 💬
|
| 10 | D-Fi | - | - | - | - | [1] 36 36 💬
|
| 11 | D-Galactose | [1] Galactose Galactose | [1] Galactose
Galactose
💬
| - | - | [1] 222 222 💬
|
| 12 | D-glucose | [1] D-glucose D-glucose | [1] Glucose
Glucose
💬
| - | - | [3] 49 49, 86, 88 💬
|
| 13 | D-IVA | - | - | - | - | [1] 299 299 💬
|
| 14 | D-Lactic acid | [2] D-Lactic acid D-Lactic acid, Lactic acid | [2] Lactic acid
Lactic acid
,
Sodium lactate
💬
| - | - | [1] 46 46 💬
|
| 15 | D-Mannitol | [1] Mannitol Mannitol | [1] Mannitol
Mannitol
💬
| - | - | [1] 21 21 💬
|
| 16 | D-methylphenidate | [1] Methylphenidate Methylphenidate | [2] Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| [2] SLC6A2 SLC6A2, SLC6A3 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 84 84 💬
|
| 17 | D-Penicillamine | [1] Penicillamine Penicillamine | [1] Penicillamine
Penicillamine
💬
| - | - | [1] 171 171 💬
|
| 18 | D-penicillamine 150mg | [1] Penicillamine Penicillamine | [1] Penicillamine
Penicillamine
💬
| - | - | [1] 171 171 💬
|
| 19 | D-penicillamine 250 mg | [1] Penicillamine Penicillamine | [1] Penicillamine
Penicillamine
💬
| - | - | [1] 171 171 💬
|
| 20 | D-Phenylalanyl-L-h | - | - | - | - | [1] 77 77 💬
|
| 21 | D-Phenylalanyl-L-he | - | - | - | - | [1] 77 77 💬
|
| 22 | D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-trypto | - | - | - | - | [1] 77 77 💬
|
| 23 | D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophan | [2] D-Tryptophan D-Tryptophan, Tryptophan | [1] Tryptophan
Tryptophan
💬
| - | - | [1] 77 77 💬
|
| 24 | D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-hemiscystyl-L-threonino | - | - | - | - | [1] 77 77 💬
|
| 25 | D-Proline | [2] D-Proline D-Proline, Proline | [1] Proline
Proline
💬
| - | - | [1] 97 97 💬
|
| 26 | D-Serine | [2] D-Serine D-Serine, Serine | [1] Serine
Serine
💬
| - | - | [1] 6 6 💬
|
| 27 | D-serine (~2g/day) | [2] D-Serine D-Serine, Serine | [1] Serine
Serine
💬
| - | - | [1] 6 6 💬
|
| 28 | D-SORBITOL | [1] Sorbitol Sorbitol | [1] Sorbitol solution
Sorbitol solution
💬
| - | - | [1] 10 10 💬
|
| 29 | D-Tryptophan | [2] D-Tryptophan D-Tryptophan, Tryptophan | [1] Tryptophan
Tryptophan
💬
| - | - | [1] 77 77 💬
|
| 30 | D.3.2 Product code where applicable13: | - | - | - | - | [1] 193 193 💬
|
| 31 | D.3.6.2 - dose massima specificare: giornaliera | - | - | - | - | [1] 86 86 💬
|
| 32 | D.3.6.2.1 - valore: 45 / 0.45 mg/ml | - | - | - | - | [1] 97 97 💬
|
| 33 | D.3.6.2.1 - valore: 5 o 10 mg/kg | - | - | - | - | [1] 97 97 💬
|
| 34 | D2E7 | - | - | - | - | [1] 46 46 💬
|
| 35 | D3 VitaCaps® | - | - | - | - | [2] 96 96, 97 💬
|
| 36 | D569 Tab. | - | - | - | - | [1] 46 46 💬
|
| 37 | D6-25-hydroxyvitamin D3 | - | - | - | - | [1] 299 299 💬
|
| 38 | D9421-C | - | - | - | - | [1] 96 96 💬
|
| 39 | D9421-C capsule 3 mg | - | - | - | - | [1] 96 96 💬
|
| 40 | D9421-C, 15mg | - | - | - | - | [1] 96 96 💬
|
| 41 | D9421-C, 9mg | - | - | - | - | [1] 96 96 💬
|
| 42 | DA-9701 | - | - | - | - | [1] 6 6 💬
|
| 43 | DA-9805 45mg | - | - | - | - | [1] 6 6 💬
|
| 44 | DA-9805 90mg | - | - | - | - | [1] 6 6 💬
|
| 45 | DAAOI-P | - | - | - | - | [1] 6 6 💬
|
| 46 | Dabigatran | [1] Dabigatran Dabigatran | [1] Dabigatran
Dabigatran
💬
| [1] F2 F2 💬
| [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | [5] 51 51, 75, 85, 91, 124 💬
|
| 47 | Dabigatran etexilate | [2] Dabigatran Dabigatran, Dabigatran etexilate | [3] Dabigatran etexilate mesylate
Dabigatran etexilate mesylate
,
Dabigatran etexilate
,
Dabigatran
💬
| [1] F2 F2 💬
| [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | [2] 51 51, 75 💬
|
| 48 | Dabocemagene autoficel | [1] Dabocemagene autoficel Dabocemagene autoficel | - | - | - | [1] 36 36 💬
|
| 49 | Dabrafenib | [1] Dabrafenib Dabrafenib | [2] Dabrafenib
Dabrafenib
,
Dabrafenib mesylate
💬
| [1] BRAF BRAF 💬
| [42] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Bladder cancer, Breast cancer, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Endometrial cancer, ErbB signaling pathway, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanoma, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Renal cell carcinoma, Serotonergic synapse, Thyroid cancer, Vascular smooth muscle contraction, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 50 | Dabu ying pills | - | - | - | - | [1] 76 76 💬
|
| 51 | DAC HYP | - | - | - | - | [1] 13 13 💬
|
| 52 | DAC-HYP | - | - | - | - | [1] 13 13 💬
|
| 53 | Dacepton 5 mg/ml | - | - | - | - | [1] 6 6 💬
|
| 54 | Dacepton 5 mg/ml infuusioneste, liuos | - | - | - | - | [1] 6 6 💬
|
| 55 | DACLIZUMAB | [1] Daclizumab Daclizumab | [1] Daclizumab
Daclizumab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [10] 13 13, 26, 56, 60, 63, 65, 97, 107, 283, 284 💬
|
| 56 | Daclizumab (Anti-CD25 Humanized Monoclonal Antibody) | [1] Daclizumab Daclizumab | [1] Daclizumab
Daclizumab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 57 | Daclizumab High Yield Process | [1] Daclizumab Daclizumab | [1] Daclizumab
Daclizumab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 58 | DACLIZUMAB HYP | [1] Daclizumab Daclizumab | [1] Daclizumab
Daclizumab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 59 | Daclizumab HYP (DAC HYP | [1] Daclizumab Daclizumab | [1] Daclizumab
Daclizumab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 60 | Daclizumab HYP (DAC HYP) | [1] Daclizumab Daclizumab | [1] Daclizumab
Daclizumab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 61 | DACLIZUMAB HYPProduct Code: BIIB019Pharmaceutical Form: Solution for injectionINN or Proposed INN: Daclizumab wih Greek suffixCurrent Sponsor code: BIIB019Other descriptive name: Daclizumab HYP (DAC HYP)Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Subcutaneous use | [1] Daclizumab Daclizumab | [1] Daclizumab
Daclizumab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 62 | Daclizumab with Greek suufix | [1] Daclizumab Daclizumab | [1] Daclizumab
Daclizumab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 63 | DACORTIN | - | - | - | - | [2] 97 97, 162 💬
|
| 64 | Dacortin ® | - | - | - | - | [1] 46 46 💬
|
| 65 | Dacortín 2,5mg | - | - | - | - | [1] 222 222 💬
|
| 66 | Dacortín 30mg | - | - | - | - | [1] 222 222 💬
|
| 67 | Dacortín 5mg | - | - | - | - | [1] 222 222 💬
|
| 68 | Daily ingestion of Lactobacillus plantarum PS128 | [1] Lactobacillus plantarum Lactobacillus plantarum | - | - | - | [1] 6 6 💬
|
| 69 | Dalacin C phosphate | - | - | - | - | [1] 46 46 💬
|
| 70 | Dalfampridine | [1] Dalfampridine Dalfampridine | [1] Dalfampridine
Dalfampridine
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [2] 4 4, 13 💬
|
| 71 | Dalfampridine 10 MG [Ampyra] | [1] Dalfampridine Dalfampridine | [1] Dalfampridine
Dalfampridine
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 💬
|
| 72 | Dalfampridine ER | [1] Dalfampridine Dalfampridine | [1] Dalfampridine
Dalfampridine
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 💬
|
| 73 | Dalfampridine ER, 10 Mg Oral Tablet, Extended Release | [1] Dalfampridine Dalfampridine | [1] Dalfampridine
Dalfampridine
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 💬
|
| 74 | Dalfampridine-ER 10mg | [1] Dalfampridine Dalfampridine | [1] Dalfampridine
Dalfampridine
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 💬
|
| 75 | Dalfampridine-ER 5mg | [1] Dalfampridine Dalfampridine | [1] Dalfampridine
Dalfampridine
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 💬
|
| 76 | Dalteparin | [1] Dalteparin Dalteparin | [1] Dalteparin sodium
Dalteparin sodium
💬
| [1] SERPINC1 SERPINC1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [3] 222 222, 223, 327 💬
|
| 77 | Dalteparin Sodium | [1] Dalteparin Dalteparin | [1] Dalteparin sodium
Dalteparin sodium
💬
| [1] SERPINC1 SERPINC1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 327 327 💬
|
| 78 | Danaparoid | [1] Danaparoid Danaparoid | [1] Danaparoid sodium
Danaparoid sodium
💬
| [1] SERPINC1 SERPINC1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 48 48 💬
|
| 79 | Danazol | [1] Danazol Danazol | [1] Danazol
Danazol
💬
| [3] AR AR, ESR1, PGR 💬
| [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [5] 60 60, 63, 64, 65, 285 💬
|
| 80 | DAND (14-Deoxyandrographolide) | - | - | - | - | [1] 97 97 💬
|
| 81 | Dandshen | - | - | - | - | [1] 222 222 💬
|
| 82 | Danicamtiv | [1] Danicamtiv Danicamtiv | [1] Danicamtiv
Danicamtiv
💬
| - | - | [1] 57 57 💬
|
| 83 | DANICOPAN | [1] Danicopan Danicopan | [1] Danicopan
Danicopan
💬
| [1] CFD CFD 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [2] 62 62, 223 💬
|
| 84 | Danicopan (ALXN2040) | [1] Danicopan Danicopan | [1] Danicopan
Danicopan
💬
| [1] CFD CFD 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [1] 62 62 💬
|
| 85 | Dantrolene | [1] Dantrolene Dantrolene | [2] Dantrolene sodium
Dantrolene sodium
,
Dantrolene
💬
| - | - | [2] 13 13, 233 💬
|
| 86 | Dantrolene sodium | [1] Dantrolene Dantrolene | [2] Dantrolene sodium
Dantrolene sodium
,
Dantrolene
💬
| - | - | [1] 233 233 💬
|
| 87 | Danzhu Fuyuan Granule | - | - | - | - | [1] 222 222 💬
|
| 88 | Dapagliflozin | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [16] 6 6, 19, 28, 40, 41, 49, 57, 66, 67, 86, 88, 97, 210, 215, 218, 222 💬
|
| 89 | Dapagliflozin 10 mg | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [1] 67 67 💬
|
| 90 | Dapagliflozin 10 MG [Farxiga] | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [2] 86 86, 88 💬
|
| 91 | Dapagliflozin 10mg Tab | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [4] 19 19, 97, 218, 222 💬
|
| 92 | Dapagliflozin and Standard therapy (ACEI or ARB). | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [1] 222 222 💬
|
| 93 | Dapagliflozin Farxiga® | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [1] 57 57 💬
|
| 94 | Dapagliflozin tablet | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [1] 210 210 💬
|
| 95 | Dapansutrile | [1] Dapansutrile Dapansutrile | [1] Dapansutrile
Dapansutrile
💬
| - | - | [1] 6 6 💬
|
| 96 | DAPIROLIZUMAB PEGOL | [1] Dapirolizumab pegol Dapirolizumab pegol | - | - | - | [2] 13 13, 49 💬
|
| 97 | Dapirolizumab pegol (DZP) | [1] Dapirolizumab pegol Dapirolizumab pegol | - | - | - | [1] 49 49 💬
|
| 98 | Dapsone | [1] Dapsone Dapsone | [1] Dapsone
Dapsone
💬
| - | - | [6] 35 35, 42, 60, 63, 84, 162 💬
|
| 99 | Dapsone (Disulone®) | [1] Dapsone Dapsone | [1] Dapsone
Dapsone
💬
| - | - | [1] 63 63 💬
|
| 100 | Dara IV | - | - | - | - | [1] 28 28 💬
|
| 101 | Dara SC | - | - | - | - | [1] 28 28 💬
|
| 102 | Daraprim | - | - | - | - | [2] 2 2, 4 💬
|
| 103 | Daratumumab | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [13] 13 13, 16, 28, 39, 46, 48, 49, 60, 63, 222, 223, 288, 331 💬
|
| 104 | DARATUMUMAB (DARZALEX®) | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 39 39 💬
|
| 105 | Daratumumab and corticosteroid treatment | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 288 288 💬
|
| 106 | Daratumumab and Hyaluronidase-fihj | [2] Daratumumab Daratumumab, Hyaluronidase | [4] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
,
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 28 28 💬
|
| 107 | Daratumumab and pomalidomide | [2] Daratumumab Daratumumab, Pomalidomide | [2] Pomalidomide
Pomalidomide
,
Daratumumab
💬
| [3] CD38 CD38, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Nicotinate and nicotinamide metabolism, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salivary secretion, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 💬
|
| 108 | Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) | [2] Daratumumab Daratumumab, Hyaluronidase | [4] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
,
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 28 28 💬
|
| 109 | Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20) | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 28 28 💬
|
| 110 | Daratumumab Injection | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [4] 16 16, 28, 49, 63 💬
|
| 111 | Daratumumab SC | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [2] 28 28, 331 💬
|
| 112 | Daratumumab(Anti-CD38 Monoclonal Antibody) | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 63 63 💬
|
| 113 | Daratumumab/daratumumab and hyaluronidase-fihj | [2] Daratumumab Daratumumab, Hyaluronidase | [4] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
,
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 28 28 💬
|
| 114 | Daridorexant | [1] Daridorexant Daridorexant | [2] Daridorexant
Daridorexant
,
Daridorexant hydrochloride
💬
| [2] HCRTR1 HCRTR1, HCRTR2 💬
| [2] Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 6 6 💬
|
| 115 | Darifenacin | [1] Darifenacin Darifenacin | [2] Darifenacin hydrobromide
Darifenacin hydrobromide
,
Darifenacin
💬
| [1] CHRM3 CHRM3 💬
| [12] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [4] 2 2, 6, 13, 26 💬
|
| 116 | Darifenacin (BAY79-4998) | [1] Darifenacin Darifenacin | [2] Darifenacin hydrobromide
Darifenacin hydrobromide
,
Darifenacin
💬
| [1] CHRM3 CHRM3 💬
| [12] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [1] 13 13 💬
|
| 117 | Darifenacin 7.5 MG Extended Release Oral Tablet | [1] Darifenacin Darifenacin | [2] Darifenacin hydrobromide
Darifenacin hydrobromide
,
Darifenacin
💬
| [1] CHRM3 CHRM3 💬
| [12] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [1] 2 2 💬
|
| 118 | Dark chocolate (85% cocoa) | [1] Cocoa Cocoa | - | - | - | [1] 6 6 💬
|
| 119 | Darunavir | [1] Darunavir Darunavir | [3] Darunavir
Darunavir
,
Darunavir ethanolate
,
Darunavir propylene glycolate
💬
| - | - | [1] 2 2 💬
|
| 120 | DARVADSTROCEL | [1] Darvadstrocel Darvadstrocel | [1] Darvadstrocel
Darvadstrocel
💬
| - | - | [1] 96 96 💬
|
| 121 | Darvocet | - | - | - | - | [1] 70 70 💬
|
| 122 | Darzalex | - | - | - | - | [3] 28 28, 49, 63 💬
|
| 123 | DARZALEX 1800 mg (daratumumab) | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 28 28 💬
|
| 124 | Darzalex Faspro (Daratumumab and hyaluronidase-fihj) | [2] Daratumumab Daratumumab, Hyaluronidase | [4] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
,
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 60 60 💬
|
| 125 | DARZALEX FASPRO (daratumumab) | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 28 28 💬
|
| 126 | DAS-001 | - | - | - | - | [1] 11 11 💬
|
| 127 | Dasatinib | [1] Dasatinib Dasatinib | [2] Dasatinib
Dasatinib
,
Dasatinib
💬
| [8] ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬
| [79] Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [3] 13 13, 51, 85 💬
|
| 128 | Dasatinib + Quercetin | [2] Dasatinib Dasatinib, Quercetin | [2] Dasatinib
Dasatinib
,
Dasatinib
💬
| [8] ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬
| [79] Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [1] 85 85 💬
|
| 129 | Dasatinib and quercetin | [2] Dasatinib Dasatinib, Quercetin | [2] Dasatinib
Dasatinib
,
Dasatinib
💬
| [8] ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬
| [79] Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [1] 13 13 💬
|
| 130 | Data collection | - | - | - | - | [1] 65 65 💬
|
| 131 | Data report | - | - | - | - | [1] 162 162 💬
|
| 132 | DaTSCAN | - | - | - | - | [3] 2 2, 5, 6 💬
|
| 133 | DaTSCAN 74 MBq/ml solution for injection | - | - | - | - | [1] 6 6 💬
|
| 134 | DATscan and SPECT imaging | - | - | - | - | [1] 6 6 💬
|
| 135 | DaTSCAN™ | - | - | - | - | [1] 6 6 💬
|
| 136 | Daunorubicin | [1] Daunorubicin Daunorubicin | [3] Daunorubicin hydrochloride
Daunorubicin hydrochloride
,
Daunorubicin
,
Daunorubicin citrate
💬
| - | - | [1] 65 65 💬
|
| 137 | Davunetide | [1] Davunetide Davunetide | [1] Davunetide
Davunetide
💬
| - | - | [3] 5 5, 7, 127 💬
|
| 138 | Davunetide (AL-108, NAP) | [1] Davunetide Davunetide | [1] Davunetide
Davunetide
💬
| - | - | [3] 5 5, 7, 127 💬
|
| 139 | Daxdilimab | [1] Daxdilimab Daxdilimab | [1] Daxdilimab
Daxdilimab
💬
| [1] LILRA4 LILRA4 💬
| [2] B cell receptor signaling pathway B cell receptor signaling pathway, Osteoclast differentiation 💬 | [2] 49 49, 50 💬
|
| 140 | DAZARLEX | - | - | - | - | [1] 28 28 💬
|
| 141 | Dazodalibep | [1] Dazodalibep Dazodalibep | - | - | - | [1] 53 53 💬
|
| 142 | Dazucorilant | [1] Dazucorilant Dazucorilant | [1] Dazucorilant
Dazucorilant
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 2 2 💬
|
| 143 | Dazucorilant 150 mg | [1] Dazucorilant Dazucorilant | [1] Dazucorilant
Dazucorilant
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 2 2 💬
|
| 144 | Dazucorilant 300 mg | [1] Dazucorilant Dazucorilant | [1] Dazucorilant
Dazucorilant
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 2 2 💬
|
| 145 | Dazukibart | [1] Dazukibart Dazukibart | [1] Dazukibart
Dazukibart
💬
| [1] IFNB1 IFNB1 💬
| [28] Alcoholic liver disease Alcoholic liver disease, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, RIG-I-like receptor signaling pathway, Shigellosis, TNF signaling pathway, Toll-like receptor signaling pathway, Tuberculosis, Yersinia infection 💬 | [1] 50 50 💬
|
| 146 | DB adalimumab 40 mg eow | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 147 | DB adalimumab 40 mg ew | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 148 | DB-2304 | - | - | - | - | [1] 49 49 💬
|
| 149 | DB-3Q | - | - | - | - | [1] 96 96 💬
|
| 150 | DBS Setting Maximizing Prefrontal Activation | - | - | - | - | [1] 6 6 💬
|
| 151 | DBS Setting Minimizing Prefrontal Activation | - | - | - | - | [1] 6 6 💬
|
| 152 | DC-TAB | - | - | - | - | [1] 13 13 💬
|
| 153 | DC158AM | - | - | - | - | [1] 6 6 💬
|
| 154 | DC6001 | - | - | - | - | [1] 301 301 💬
|
| 155 | DCCR | - | - | - | - | [1] 193 193 💬
|
| 156 | DCCR (Diazoxide Choline) Extended- Release Tablet | [2] Choline Choline, Diazoxide | [3] Diazoxide
Diazoxide
,
Choline
,
Diazoxide choline
💬
| [2] ABCC8 ABCC8, KCNJ11 💬
| [4] ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [1] 193 193 💬
|
| 157 | DCI 1020 | - | - | - | - | [1] 299 299 💬
|
| 158 | DCP | - | - | - | - | [1] 115 115 💬
|
| 159 | DCR-1171X | - | - | - | - | [1] 234 234 💬
|
| 160 | DCR-L1360 | - | - | - | - | [1] 234 234 💬
|
| 161 | DCR-PH1 | [1] DCR-PH1 DCR-PH1 | - | - | - | [1] 234 234 💬
|
| 162 | DCR-PHXC | - | - | - | - | [1] 234 234 💬
|
| 163 | DDAND (14-deoxy-11,12-didehydroandrographolide) | - | - | - | - | [1] 97 97 💬
|
| 164 | De-activated smart device | - | - | - | - | [1] 299 299 💬
|
| 165 | Deanol | [1] Deanol Deanol | [1] Deanol
Deanol
💬
| - | - | [1] 6 6 💬
|
| 166 | Deanol pyroglutamate | [1] Deanol Deanol | [1] Deanol
Deanol
💬
| - | - | [1] 6 6 💬
|
| 167 | Deaxamethasone | - | - | - | - | [1] 28 28 💬
|
| 168 | Debamestrocel | [1] Debamestrocel Debamestrocel | - | - | - | [1] 2 2 💬
|
| 169 | Debamestrocel - MSC-NTF (NurOwn) | [1] Debamestrocel Debamestrocel | - | - | - | [1] 2 2 💬
|
| 170 | Debio 4126 | - | - | - | - | [1] 77 77 💬
|
| 171 | Debio 4326 | - | - | - | - | [1] 76 76 💬
|
| 172 | DEBRUMYL | - | - | - | - | [1] 6 6 💬
|
| 173 | Decadron | - | - | - | - | [1] 28 28 💬
|
| 174 | Decadron Phosphate, Injectable | - | - | - | - | [1] 70 70 💬
|
| 175 | Decartes-08 | - | - | - | - | [1] 11 11 💬
|
| 176 | Decitabine | [1] Decitabine Decitabine | [1] Decitabine
Decitabine
💬
| [3] DNMT1 DNMT1, DNMT3A, DNMT3B 💬
| [3] Cysteine and methionine metabolism Cysteine and methionine metabolism, Efferocytosis, MicroRNAs in cancer 💬 | [2] 60 60, 63 💬
|
| 177 | Decolonization | - | - | - | - | [1] 299 299 💬
|
| 178 | Decortin | - | - | - | - | [2] 46 46, 113 💬
|
| 179 | DECORTIN (PREDNISONA) 5 MG COMPRIMIDOS | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 180 | Decortin 20 mg | - | - | - | - | [1] 96 96 💬
|
| 181 | Decortin 5 mg | - | - | - | - | [1] 96 96 💬
|
| 182 | Decortin 5mg tablets | - | - | - | - | [1] 46 46 💬
|
| 183 | Decortin H | - | - | - | - | [2] 66 66, 145 💬
|
| 184 | Decortin H 1 mg | - | - | - | - | [1] 97 97 💬
|
| 185 | Decortin H 10mg | - | - | - | - | [1] 97 97 💬
|
| 186 | Decortin H 20mg | - | - | - | - | [1] 97 97 💬
|
| 187 | Decortin H 50 mg | - | - | - | - | [1] 97 97 💬
|
| 188 | Decortin H 5mg | - | - | - | - | [1] 97 97 💬
|
| 189 | Decortin® | - | - | - | - | [1] 46 46 💬
|
| 190 | Decrease Tocilizumab, Abatacept | [2] Abatacept Abatacept, Tocilizumab | [2] Tocilizumab
Tocilizumab
,
Abatacept
💬
| [3] CD80 CD80, CD86, IL6R 💬
| [25] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Coronavirus disease, Cytokine-cytokine receptor interaction, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 191 | Dectancyl | - | - | - | - | [1] 81 81 💬
|
| 192 | Deep Brain Stimulation | - | - | - | - | [5] 5 5, 6, 7, 8, 17 💬
|
| 193 | Defanyl 50 and 100 mg | - | - | - | - | [1] 46 46 💬
|
| 194 | Deferasirox | [1] Deferasirox Deferasirox | [1] Deferasirox
Deferasirox
💬
| - | - | [5] 54 54, 60, 254, 284, 286 💬
|
| 195 | DEFERIPRONE | [1] Deferiprone Deferiprone | [1] Deferiprone
Deferiprone
💬
| - | - | [7] 2 2, 6, 18, 121, 122, 139, 233 💬
|
| 196 | Deferiprone (Ferriprox) | [1] Deferiprone Deferiprone | [1] Deferiprone
Deferiprone
💬
| - | - | [2] 6 6, 139 💬
|
| 197 | Deferiprone 20mg | [1] Deferiprone Deferiprone | [1] Deferiprone
Deferiprone
💬
| - | - | [1] 6 6 💬
|
| 198 | Deferiprone 30mg | [1] Deferiprone Deferiprone | [1] Deferiprone
Deferiprone
💬
| - | - | [1] 6 6 💬
|
| 199 | Deferiprone 600 mg delayed release tablet | [1] Deferiprone Deferiprone | [1] Deferiprone
Deferiprone
💬
| - | - | [1] 6 6 💬
|
| 200 | Deferiprone 80 mg/mL oral solution | [1] Deferiprone Deferiprone | [1] Deferiprone
Deferiprone
💬
| - | - | [1] 121 121 💬
|
| 201 | Deferiprone 80 mg/mL oral solution (Ferriprox) | [1] Deferiprone Deferiprone | [1] Deferiprone
Deferiprone
💬
| - | - | [1] 121 121 💬
|
| 202 | Deferiprone DR | [1] Deferiprone Deferiprone | [1] Deferiprone
Deferiprone
💬
| - | - | [2] 2 2, 6 💬
|
| 203 | Deferiprone oral solution | [1] Deferiprone Deferiprone | [1] Deferiprone
Deferiprone
💬
| - | - | [1] 121 121 💬
|
| 204 | Deferitazole | [1] Deferitazole Deferitazole | [1] Deferitazole
Deferitazole
💬
| - | - | [1] 284 284 💬
|
| 205 | Deferoxamine | [1] Deferoxamine Deferoxamine | [3] Deferoxamine mesylate
Deferoxamine mesylate
,
Deferoxamine
,
Deferoxamine hydrochloride
💬
| - | - | [2] 284 284, 286 💬
|
| 206 | DEFEROXAMINE MESILATE | [1] Deferoxamine Deferoxamine | [3] Deferoxamine mesylate
Deferoxamine mesylate
,
Deferoxamine
,
Deferoxamine hydrochloride
💬
| - | - | [1] 286 286 💬
|
| 207 | Definity Perflutren Lipid Microsphere Ultrasound Contrast | [1] Perflutren Perflutren | [1] Perflutren
Perflutren
💬
| - | - | [1] 70 70 💬
|
| 208 | Definity® Vial for (Perflutren Lipid Microsphere) Injectable Suspension | [1] Perflutren Perflutren | [1] Perflutren
Perflutren
💬
| - | - | [1] 2 2 💬
|
| 209 | DEFLAN*10CPR 6MG | - | - | - | - | [1] 113 113 💬
|
| 210 | Deflazacort | [1] Deflazacort Deflazacort | [1] Deflazacort
Deflazacort
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 30 30, 113 💬
|
| 211 | Deflazacort 6 mg Tablets | [1] Deflazacort Deflazacort | [1] Deflazacort
Deflazacort
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 💬
|
| 212 | DEFLEGMIN 75mg, kapsulki o przedluzonym uwalnianiu | - | - | - | - | [1] 19 19 💬
|
| 213 | Dehydrated Alcohol (Absolute Alcohol) BP for Injection | [1] Ethanol Ethanol | [2] Alcohol
Alcohol
,
Ethanol
💬
| - | - | [1] 279 279 💬
|
| 214 | Dehydrated human amnion/chorion membrane | - | - | - | - | [1] 269 269 💬
|
| 215 | Dehydroepiandrosterone | - | - | - | - | [3] 49 49, 53, 83 💬
|
| 216 | Dehydroepiandrosterone (DHEA) | - | - | - | - | [1] 49 49 💬
|
| 217 | Dehydroepiandrosterone 100 and 400 mg | - | - | - | - | [1] 113 113 💬
|
| 218 | Dehydroepiandrosterone [DHEA] | - | - | - | - | [1] 96 96 💬
|
| 219 | Dekavil | - | - | - | - | [2] 46 46, 97 💬
|
| 220 | Dekristol | - | - | - | - | [2] 13 13, 97 💬
|
| 221 | Dekristol 20.000 ie | - | - | - | - | [1] 96 96 💬
|
| 222 | Dekristol 20000 IE | - | - | - | - | [1] 13 13 💬
|
| 223 | Dekristol® 400-Tabletten | - | - | - | - | [1] 13 13 💬
|
| 224 | Dekristol®-Tablette 1 (400 IE) | - | - | - | - | [1] 13 13 💬
|
| 225 | Deksmedetomidiini | - | - | - | - | [1] 70 70 💬
|
| 226 | Del-desiran (AOC 1001) | [1] AOC 1001 AOC 1001 | [1] Delpacibart
Delpacibart
💬
| [1] TFRC TFRC 💬
| [6] Endocytosis Endocytosis, Ferroptosis, HIF-1 signaling pathway, Hematopoietic cell lineage, TGF-beta signaling pathway, Virion - Lassa virus and SFTS virus 💬 | [1] 113 113 💬
|
| 227 | Delandistrogene moxeparvovec | [1] Delandistrogene moxeparvovec Delandistrogene moxeparvovec | [1] Delandistrogene moxeparvovec
Delandistrogene moxeparvovec
💬
| [1] DMD DMD 💬
| [5] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | [1] 113 113 💬
|
| 228 | Delandistrogene moxeparvovec (SRP-9001) | [1] Delandistrogene moxeparvovec Delandistrogene moxeparvovec | [1] Delandistrogene moxeparvovec
Delandistrogene moxeparvovec
💬
| [1] DMD DMD 💬
| [5] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | [1] 113 113 💬
|
| 229 | Delandistrogene moxeparvovecProduct Code: RO7494222 (SRP-9001)Pharmaceutical Form: Solution for infusionINN or Proposed INN: delandistrogene moxeparvovecCAS Number: 2305040-16-6Current Sponsor code: RO7494222 (SRP-9001)Other descriptive name: Delandistrogene moxeparvovecConcentration unit: vector genomes (vg)/mLConcentration type: equalConcentration number: 1.33 x 10^13- | - | - | - | - | [1] 113 113 💬
|
| 230 | Delayed and extended release mesalazine | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 231 | Delayed Release 6 mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 96 96 💬
|
| 232 | Delayed Release 6MP or Calcitriol vs. Purinethol | [1] Calcitriol Calcitriol | [1] Calcitriol
Calcitriol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬
|
| 233 | Delgocitinib | [1] Delgocitinib Delgocitinib | [1] Delgocitinib
Delgocitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 50 50 💬
|
| 234 | Deligoparin | - | - | - | - | [1] 97 97 💬
|
| 235 | Delix | - | - | - | - | [1] 218 218 💬
|
| 236 | Delmitide | [1] Delmitide Delmitide | - | - | - | [1] 97 97 💬
|
| 237 | Delmitide acetate | [2] Acetate Acetate, Delmitide | - | - | - | [1] 97 97 💬
|
| 238 | Delpacibart zotadirsen | - | - | - | - | [1] 113 113 💬
|
| 239 | DELTA-9-TETRAHYDROCANNABINOL | - | - | - | - | [2] 13 13, 36 💬
|
| 240 | Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 8 8 💬
|
| 241 | DELTACORTENE | - | - | - | - | [2] 43 43, 97 💬
|
| 242 | Deltacortene 10 cpr 25mg | - | - | - | - | [1] 97 97 💬
|
| 243 | Deltacortene 20 cpr 5mg | - | - | - | - | [1] 97 97 💬
|
| 244 | DELTACORTENE FORTE*10CPR 25MG | - | - | - | - | [2] 46 46, 97 💬
|
| 245 | DELTACORTENE*10CPR 25MG | - | - | - | - | [1] 84 84 💬
|
| 246 | DELTACORTENE*20CPR 5MG | - | - | - | - | [3] 49 49, 97, 113 💬
|
| 247 | Deltacortril Enteric | - | - | - | - | [1] 46 46 💬
|
| 248 | DEMESTRIL SEPTEM | - | - | - | - | [1] 13 13 💬
|
| 249 | Demineralized Bone Matrix | - | - | - | - | [1] 70 70 💬
|
| 250 | Dengue 1,2,3,4 (attenuated) vaccine | - | - | - | - | [8] 40 40, 43, 44, 46, 48, 49, 51, 107 💬
|
| 251 | Denosumab | [1] Denosumab Denosumab | [1] Denosumab
Denosumab
💬
| [1] TNFSF11 TNFSF11 💬
| [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [11] 46 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬
|
| 252 | Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand | [1] Denosumab Denosumab | [1] Denosumab
Denosumab
💬
| [1] TNFSF11 TNFSF11 💬
| [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [1] 274 274 💬
|
| 253 | Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand | [1] Denosumab Denosumab | [1] Denosumab
Denosumab
💬
| [1] TNFSF11 TNFSF11 💬
| [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [1] 274 274 💬
|
| 254 | DENSITYTM caplets (marketed as Amorphical) | - | - | - | - | [1] 97 97 💬
|
| 255 | Denufosol | [1] Denufosol Denufosol | [1] Denufosol tetrasodium
Denufosol tetrasodium
💬
| [1] P2RY2 P2RY2 💬
| [4] Efferocytosis Efferocytosis, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 299 299 💬
|
| 256 | Denufosol tetrasodium (INS37217) | [1] Denufosol Denufosol | [1] Denufosol tetrasodium
Denufosol tetrasodium
💬
| [1] P2RY2 P2RY2 💬
| [4] Efferocytosis Efferocytosis, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 299 299 💬
|
| 257 | Denufosol Tetrasodium (INS37217) Inhalation Solution | [1] Denufosol Denufosol | [1] Denufosol tetrasodium
Denufosol tetrasodium
💬
| [1] P2RY2 P2RY2 💬
| [4] Efferocytosis Efferocytosis, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 299 299 💬
|
| 258 | Denufosol tetrasodium Inhalation Solution | [1] Denufosol Denufosol | [1] Denufosol tetrasodium
Denufosol tetrasodium
💬
| [1] P2RY2 P2RY2 💬
| [4] Efferocytosis Efferocytosis, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 299 299 💬
|
| 259 | Denusomab | - | - | - | - | [1] 274 274 💬
|
| 260 | Deoxycholic Acid | [1] Deoxycholic acid Deoxycholic acid | [1] Deoxycholic acid
Deoxycholic acid
💬
| - | - | [1] 34 34 💬
|
| 261 | Deoxycytidine | - | - | - | - | [1] 65 65 💬
|
| 262 | Deoxythymidine | - | - | - | - | [1] 65 65 💬
|
| 263 | Depakine | - | - | - | - | [2] 102 102, 233 💬
|
| 264 | DEPAKINE CHRONO 500 mg | - | - | - | - | [1] 233 233 💬
|
| 265 | Depakine Chrono 500© | - | - | - | - | [1] 222 222 💬
|
| 266 | DEPAKINE CHRONO® 500 mg | - | - | - | - | [1] 233 233 💬
|
| 267 | DEPALGOS*20+325MG 28CPR RP | - | - | - | - | [1] 46 46 💬
|
| 268 | DEPELESTAT | [1] Depelestat Depelestat | [1] Depelestat
Depelestat
💬
| [1] ELANE ELANE 💬
| [4] Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Phagocytosis, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬 | [1] 299 299 💬
|
| 269 | Depemedrone | - | - | - | - | [1] 46 46 💬
|
| 270 | Depemokimab | [1] Depemokimab Depemokimab | [1] Depemokimab
Depemokimab
💬
| [1] IL5 IL5 💬
| [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [2] 44 44, 45 💬
|
| 271 | Depleted Stem Cell Transplant | - | - | - | - | [1] 285 285 💬
|
| 272 | Depletion of CD3/CD19 in an autologous stem cell transplant | - | - | - | - | [2] 49 49, 51 💬
|
| 273 | Depo Medrol | - | - | - | - | [1] 46 46 💬
|
| 274 | Depo-Medrol 40Mg/Ml Suspension for Injection | - | - | - | - | [1] 70 70 💬
|
| 275 | Depo-Medrone | - | - | - | - | [1] 46 46 💬
|
| 276 | DepoMedrol | - | - | - | - | [3] 70 70, 222, 223 💬
|
| 277 | Depot leuprolide acetate 3.75 mg | [2] Acetate Acetate, Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 278 | Depot tetracosactide | [1] Tetracosactide Tetracosactide | [2] Cosyntropin
Cosyntropin
,
Tetracosactide acetate
💬
| [1] MC2R MC2R 💬
| [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 83 83 💬
|
| 279 | Deprakine | - | - | - | - | [1] 256 256 💬
|
| 280 | Deramiocel (CAP-1002) | - | - | - | - | [1] 113 113 💬
|
| 281 | Dermoval | - | - | - | - | [2] 35 35, 162 💬
|
| 282 | Dersalazina sodica | - | - | - | - | [1] 97 97 💬
|
| 283 | Dersalazine | [1] Dersalazine Dersalazine | - | - | - | [1] 97 97 💬
|
| 284 | Dersalazine sodium | [1] Dersalazine Dersalazine | - | - | - | [1] 97 97 💬
|
| 285 | Dersimelagon | [1] Dersimelagon Dersimelagon | [1] Dersimelagon
Dersimelagon
💬
| [1] MC1R MC1R 💬
| [3] Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [2] 51 51, 254 💬
|
| 286 | DESAMETASONE | - | - | - | - | [3] 28 28, 63, 90 💬
|
| 287 | Desametasone 40mg | - | - | - | - | [1] 63 63 💬
|
| 288 | DESAMETASONE SODIO FOSFATO | - | - | - | - | [1] 28 28 💬
|
| 289 | Descartes-08 | - | - | - | - | [3] 11 11, 49, 50 💬
|
| 290 | Desert Harvest Aloe Vera Capsules | - | - | - | - | [1] 226 226 💬
|
| 291 | Desferal | - | - | - | - | [2] 284 284, 286 💬
|
| 292 | Desferasirox | - | - | - | - | [1] 60 60 💬
|
| 293 | Desflurane | [1] Desflurane Desflurane | [1] Desflurane
Desflurane
💬
| - | - | [2] 22 22, 296 💬
|
| 294 | Desflurane anesthetics | [1] Desflurane Desflurane | [1] Desflurane
Desflurane
💬
| - | - | [1] 296 296 💬
|
| 295 | Desipramine | [1] Desipramine Desipramine | [2] Desipramine hydrochloride
Desipramine hydrochloride
,
Desipramine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 121 121, 156 💬
|
| 296 | Desloratadine | [1] Desloratadine Desloratadine | [1] Desloratadine
Desloratadine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [3] 13 13, 46, 97 💬
|
| 297 | Desloratadine 5 mg | [1] Desloratadine Desloratadine | [1] Desloratadine
Desloratadine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 298 | Desloratadine given orally | [1] Desloratadine Desloratadine | [1] Desloratadine
Desloratadine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 299 | Desmopressin | [1] Desmopressin Desmopressin | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [8] 6 6, 22, 64, 72, 75, 223, 225, 288 💬
|
| 300 | Desmopressin Acetat | [1] Desmopressin Desmopressin | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 6 6 💬
|
| 301 | Desmopressin acetate | [2] Acetate Acetate, Desmopressin | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 64 64, 75 💬
|
| 302 | DESMOPRESSIN ACETATE TRIHYDRATE | [2] Acetate Acetate, Desmopressin | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 225 225 💬
|
| 303 | Desmopressin intranasal | [1] Desmopressin Desmopressin | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 72 72 💬
|
| 304 | Desmopressin Oral Melt | [1] Desmopressin Desmopressin | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 72 72 💬
|
| 305 | Desmopressine nasal spray 10 mg/ml, flacon 60 doses | [1] Desmopressin Desmopressin | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 225 225 💬
|
| 306 | Desmotabs | - | - | - | - | [1] 6 6 💬
|
| 307 | Desmotabs® 0,2 mg Tabletten | - | - | - | - | [1] 6 6 💬
|
| 308 | Desmotabs® 0,2mg Tabletten | - | - | - | - | [1] 6 6 💬
|
| 309 | Desogestrel | [1] Desogestrel Desogestrel | [1] Desogestrel
Desogestrel
💬
| [2] ESR1 ESR1, PGR 💬
| [11] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 230 230 💬
|
| 310 | Desoxyribonuclease | [1] Desoxyribonuclease Desoxyribonuclease | - | - | - | [1] 299 299 💬
|
| 311 | Determination of beta-hydroxybutyrate (BHB) in capillary blood | - | - | - | - | [1] 84 84 💬
|
| 312 | Determination of drug effects through amantadine cessation | [1] Amantadine Amantadine | [2] Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 313 | Determination of objective and subjective pain threshold | - | - | - | - | [1] 17 17 💬
|
| 314 | Detoxifying agents for antineoplastic treatment | - | - | - | - | [2] 299 299, 337 💬
|
| 315 | Deucravacitinb | - | - | - | - | [1] 50 50 💬
|
| 316 | Deucravacitinib | [1] Deucravacitinib Deucravacitinib | [1] Deucravacitinib
Deucravacitinib
💬
| [1] TYK2 TYK2 💬
| [17] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | [10] 36 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
|
| 317 | Deucrictibant | [1] Deucrictibant Deucrictibant | [1] Deucrictibant
Deucrictibant
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 318 | Deucrictibant 20 mg capsule | [1] Deucrictibant Deucrictibant | [1] Deucrictibant
Deucrictibant
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 319 | Deucrictibant high dose | [1] Deucrictibant Deucrictibant | [1] Deucrictibant
Deucrictibant
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 320 | Deucrictibant low dose | [1] Deucrictibant Deucrictibant | [1] Deucrictibant
Deucrictibant
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 321 | Deucrictibant XR tablet | [1] Deucrictibant Deucrictibant | [1] Deucrictibant
Deucrictibant
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 322 | Deupirfenidone | [1] Deupirfenidone Deupirfenidone | [1] Deupirfenidone
Deupirfenidone
💬
| - | - | [1] 85 85 💬
|
| 323 | Deuterated Ivacaftor | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 324 | Deutetrabenazine | [1] Deutetrabenazine Deutetrabenazine | [1] Deutetrabenazine
Deutetrabenazine
💬
| [1] SLC18A2 SLC18A2 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 8 8 💬
|
| 325 | Deutetrabenazine Oral Tablet [Austedo] | [1] Deutetrabenazine Deutetrabenazine | [1] Deutetrabenazine
Deutetrabenazine
💬
| [1] SLC18A2 SLC18A2 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 8 8 💬
|
| 326 | DEUTIVACAFTOR | [1] Deutivacaftor Deutivacaftor | [1] Deutivacaftor
Deutivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 327 | Device: Active stimulation | - | - | - | - | [1] 13 13 💬
|
| 328 | Device: Non-active stimulation | - | - | - | - | [1] 13 13 💬
|
| 329 | Dex 21-P | - | - | - | - | [1] 97 97 💬
|
| 330 | DEX Combined With RTX, CSA and IVIG | - | - | - | - | [1] 63 63 💬
|
| 331 | DEX284 | - | - | - | - | [1] 85 85 💬
|
| 332 | DEXA scan | - | - | - | - | [3] 19 19, 46, 96 💬
|
| 333 | DEXA, blood tests, H.G.P.O, osseous age. | - | - | - | - | [1] 193 193 💬
|
| 334 | Dexametasone | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 335 | Dexametasone Fosfato Sodico | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 336 | Dexametasone sodium phosphate | - | - | - | - | [2] 96 96, 97 💬
|
| 337 | Dexamethason | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [4] 13 13, 28, 46, 331 💬
|
| 338 | Dexamethasone | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [29] 13 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
|
| 339 | Dexamethasone (1 cycle) | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 340 | Dexamethasone (4 cycles) | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 341 | Dexamethasone (50mg 1dd6, 3 consecutive days/month) | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬
|
| 342 | Dexamethasone (IV) | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 96 96, 97 💬
|
| 343 | Dexamethasone (or equivalent) | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 257 257 💬
|
| 344 | Dexamethasone 0,1 mg Tablets | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 345 | Dexamethasone 0,5mg | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 💬
|
| 346 | Dexamethasone 0.5mg Tablet | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 347 | Dexamethasone 0.5mg/5ml solution | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 35 35, 162 💬
|
| 348 | Dexamethasone 0.5mg/5ml solution in Mucolox™ | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 35 35, 162 💬
|
| 349 | Dexamethasone 1,5 mg Tablets | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 350 | Dexamethasone 2mg Tablets | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 351 | Dexamethasone 4 mg JENAPHARM | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 352 | Dexamethasone 4 Mg/mL Injectable Solution | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 70 70 💬
|
| 353 | Dexamethasone Abcur | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 354 | DEXAMETHASONE ACETATE | [3] Acetate Acetate, Dexamethasone, Dexamethasone acetate | [5] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone acetate
,
Dexamethasone 21-acetate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 355 | Dexamethasone and Rituximab | [2] Dexamethasone Dexamethasone, Rituximab | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Rituximab
,
Dexamethasone phosphate
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 356 | Dexamethasone Azathioprine Pulse therapy | [2] Azathioprine Azathioprine, Dexamethasone | [5] Azathioprine
Azathioprine
,
Dexamethasone
,
Dexamethasone sodium phosphate
,
Azathioprine sodium
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬
|
| 357 | Dexamethasone Combined with romiplostim N01 | [2] Dexamethasone Dexamethasone, Romiplostim | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
,
Romiplostim
💬
| [2] MPL MPL, NR3C1 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 358 | Dexamethasone Cyclophosphamide Pulse therapy | [2] Cyclophosphamide Cyclophosphamide, Dexamethasone | [5] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Dexamethasone sodium phosphate
,
Cyclophosphamide
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬
|
| 359 | Dexamethasone given orally | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 360 | Dexamethasone injection | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 90 90 💬
|
| 361 | Dexamethasone Krka | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 362 | Dexamethasone monotherapy | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 363 | Dexamethasone oral | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 364 | Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland). | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 235 235 💬
|
| 365 | Dexamethasone Oral, 10 mg | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 366 | Dexamethasone Oral, 20 mg | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 367 | Dexamethasone palmitate | [2] Dexamethasone Dexamethasone, Dexamethasone palmitate | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone palmitate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 368 | Dexamethasone Parotid Irrigation | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 53 53 💬
|
| 369 | DEXAMETHASONE SODIUM PHOSPHATE | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 65 65, 70, 96 💬
|
| 370 | Dexamethasone sodium phosphate (soluzione 25mg/ml) | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 371 | Dexamethasone sodium phosphate 250 mg/ 10 ml | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 💬
|
| 372 | Dexamethasone sodium phosphate 250 mg/10 ml solution | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 299 299 💬
|
| 373 | DEXAMETHASONE SODIUM PHOSPHATE PH. EUR. | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 374 | DEXAMETHASONE SODIUM SULFATE | [2] Dexamethasone Dexamethasone, Sodium sulfate | [5] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Anhydous sodium sulfate
,
Sodium sulfate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 375 | Dexamethasone soduim phosphate | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 376 | Dexamethasone USP Micronized | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 377 | Dexamethasone, 40 mg | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬
|
| 378 | Dexamethasone, procarbazine | [2] Dexamethasone Dexamethasone, Procarbazine | [5] Dexamethasone
Dexamethasone
,
Procarbazine hydrochloride
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
,
Procarbazine
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 379 | Dexaton | - | - | - | - | [1] 28 28 💬
|
| 380 | Dexchlorpheniramine | [1] Dexchlorpheniramine Dexchlorpheniramine | [1] Dexchlorpheniramine
Dexchlorpheniramine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 49 💬
|
| 381 | Dexdor | - | - | - | - | [4] 2 2, 4, 6, 70 💬
|
| 382 | Dexlansoprazole | [1] Dexlansoprazole Dexlansoprazole | [2] Dexlansoprazole
Dexlansoprazole
,
Dexlansoprazole sesquihydrate
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 98 98 💬
|
| 383 | DEXMEDETOMIDINA | [1] Dexmedetomidine Dexmedetomidine | [2] Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 384 | DEXMEDETOMIDINE | [1] Dexmedetomidine Dexmedetomidine | [2] Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [15] 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
| 385 | Dexmedetomidine 1 | [1] Dexmedetomidine Dexmedetomidine | [2] Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 280 280 💬
|
| 386 | Dexmedetomidine 2 | [1] Dexmedetomidine Dexmedetomidine | [2] Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 280 280 💬
|
| 387 | Dexmedetomidine 3 | [1] Dexmedetomidine Dexmedetomidine | [2] Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 280 280 💬
|
| 388 | Dexmedetomidine group | [1] Dexmedetomidine Dexmedetomidine | [2] Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬
|
| 389 | Dexmedetomidine Hcl 100 Mcg/mL Inj | [1] Dexmedetomidine Dexmedetomidine | [2] Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 215 215 💬
|
| 390 | DEXMEDETOMIDINE HYDROCHLORIDE | [1] Dexmedetomidine Dexmedetomidine | [2] Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬
|
| 391 | Dexmedetomidine Hydrochloride Infusion | [1] Dexmedetomidine Dexmedetomidine | [2] Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 392 | Dexmedetomidine injection | [1] Dexmedetomidine Dexmedetomidine | [2] Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬
|
| 393 | Dexmedetomidine with ropivacaine | [2] Dexmedetomidine Dexmedetomidine, Ropivacaine | [4] Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
,
Ropivacaine hydrochloride
,
Ropivacaine
💬
| [9] ADRA2A ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬
|
| 394 | DexmedetomidineProduct Name: DexdorPharmaceutical Form: Concentrate and solvent for solution for infusionINN or Proposed INN: DEXMEDETOMIDINECAS Number: 113775-47-6Pharmaceutical form of the placebo: Concentrate and solvent for solution for infusionRoute of administration of the placebo: Intravenous use | - | - | - | - | [1] 70 70 💬
|
| 395 | Dexpramipexole | [1] Dexpramipexole Dexpramipexole | [2] Dexpramipexole
Dexpramipexole
,
Dexpramipexole dihydrochloride
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 396 | Dexpramipexole (dose 1) | [1] Dexpramipexole Dexpramipexole | [2] Dexpramipexole
Dexpramipexole
,
Dexpramipexole dihydrochloride
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 397 | Dexpramipexole (dose 2) | [1] Dexpramipexole Dexpramipexole | [2] Dexpramipexole
Dexpramipexole
,
Dexpramipexole dihydrochloride
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 398 | Dexpramipexole Dichydrochloride | [1] Dexpramipexole Dexpramipexole | [2] Dexpramipexole
Dexpramipexole
,
Dexpramipexole dihydrochloride
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 399 | Dexpramipexole Dihydrochloride | [1] Dexpramipexole Dexpramipexole | [2] Dexpramipexole
Dexpramipexole
,
Dexpramipexole dihydrochloride
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 400 | Dexrazoxane | [1] Dexrazoxane Dexrazoxane | [2] Dexrazoxane
Dexrazoxane
,
Dexrazoxane hydrochloride
💬
| - | - | [1] 13 13 💬
|
| 401 | Dexrazoxane (DRZ) plus Mitoxantrone (MX) | [2] Dexrazoxane Dexrazoxane, Mitoxantrone | [4] Mitoxantrone hydrochloride
Mitoxantrone hydrochloride
,
Dexrazoxane
,
Dexrazoxane hydrochloride
,
Mitoxantrone
💬
| - | - | [1] 13 13 💬
|
| 402 | Dextran | [1] Dextran Dextran | [5] Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [5] 2 2, 62, 79, 96, 97 💬
|
| 403 | Dextran 1 | [2] Dextran Dextran, Dextran 1 | [5] Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [1] 97 97 💬
|
| 404 | DEXTRAN 1 FOR INJECTION | [2] Dextran Dextran, Dextran 1 | [5] Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [1] 97 97 💬
|
| 405 | Dextran Sodium Sulfur Salt 5, Mw 5 kDa. a type of Low Molecular Weight Dextran Sulfate (LMW-DS) | [1] Dextran Dextran | [5] Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [1] 2 2 💬
|
| 406 | Dextran sulfate adsorption | [1] Dextran Dextran | [5] Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [1] 79 79 💬
|
| 407 | DEXTRAN SULFATE SODIUM | [1] Dextran Dextran | [5] Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [1] 2 2 💬
|
| 408 | Dextromethorphan | [1] Dextromethorphan Dextromethorphan | [3] Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Dextromethorphan polistirex
💬
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [10] 2 2, 6, 8, 13, 21, 46, 85, 96, 97, 156 💬
|
| 409 | Dextromethorphan 30 mg | [1] Dextromethorphan Dextromethorphan | [3] Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Dextromethorphan polistirex
💬
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [2] 96 96, 97 💬
|
| 410 | Dextromethorphan HBr and quinidine sulfate | [2] Dextromethorphan Dextromethorphan, Quinidine | [7] Quinidine gluconate
Quinidine gluconate
,
Quinidine polygalacturonate
,
Dextromethorphan hydrobromide
,
Quinidine sulfate
,
Dextromethorphan
,
Dextromethorphan polistirex
,
Quinidine
💬
| [12] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SIGMAR1 💬
| [25] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Cadherin signaling, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, IgSF CAM signaling, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 411 | DEXTROMETHORPHAN HYDROBROMIDE | [1] Dextromethorphan Dextromethorphan | [3] Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Dextromethorphan polistirex
💬
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [2] 13 13, 46 💬
|
| 412 | Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg | [2] Dextromethorphan Dextromethorphan, Quinidine | [7] Quinidine gluconate
Quinidine gluconate
,
Quinidine polygalacturonate
,
Dextromethorphan hydrobromide
,
Quinidine sulfate
,
Dextromethorphan
,
Dextromethorphan polistirex
,
Quinidine
💬
| [12] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SIGMAR1 💬
| [25] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Cadherin signaling, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, IgSF CAM signaling, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [2] 2 2, 13 💬
|
| 413 | Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg | [2] Dextromethorphan Dextromethorphan, Quinidine | [7] Quinidine gluconate
Quinidine gluconate
,
Quinidine polygalacturonate
,
Dextromethorphan hydrobromide
,
Quinidine sulfate
,
Dextromethorphan
,
Dextromethorphan polistirex
,
Quinidine
💬
| [12] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SIGMAR1 💬
| [25] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Cadherin signaling, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, IgSF CAM signaling, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [2] 2 2, 13 💬
|
| 414 | Dextromethorphan/Quinidine | [2] Dextromethorphan Dextromethorphan, Quinidine | [7] Quinidine gluconate
Quinidine gluconate
,
Quinidine polygalacturonate
,
Dextromethorphan hydrobromide
,
Quinidine sulfate
,
Dextromethorphan
,
Dextromethorphan polistirex
,
Quinidine
💬
| [12] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SIGMAR1 💬
| [25] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Cadherin signaling, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, IgSF CAM signaling, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 415 | Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg) | [2] Dextromethorphan Dextromethorphan, Quinidine | [7] Quinidine gluconate
Quinidine gluconate
,
Quinidine polygalacturonate
,
Dextromethorphan hydrobromide
,
Quinidine sulfate
,
Dextromethorphan
,
Dextromethorphan polistirex
,
Quinidine
💬
| [12] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SIGMAR1 💬
| [25] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Cadherin signaling, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, IgSF CAM signaling, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [1] 8 8 💬
|
| 416 | DEXTROMETORFANO HIDROBROMURO | - | - | - | - | [1] 13 13 💬
|
| 417 | Dextrometorfano/Quinidina | - | - | - | - | [1] 13 13 💬
|
| 418 | Dextrose | - | - | - | - | [1] 226 226 💬
|
| 419 | Dextrose 50% Intravenous Solution | - | - | - | - | [1] 168 168 💬
|
| 420 | Dextrose, 5% in Water | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 65 65 💬
|
| 421 | Dezamizumab | [1] Dezamizumab Dezamizumab | [1] Dezamizumab
Dezamizumab
💬
| - | - | [1] 28 28 💬
|
| 422 | Dezocine | [1] Dezocine Dezocine | [1] Dezocine
Dezocine
💬
| [2] OPRK1 OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 423 | DF2156A | - | - | - | - | [1] 162 162 💬
|
| 424 | DFO | - | - | - | - | [2] 284 284, 286 💬
|
| 425 | DFV890 | [1] DFV890 DFV890 | - | - | - | [1] 106 106 💬
|
| 426 | DG3173 | - | - | - | - | [1] 77 77 💬
|
| 427 | DHA | - | - | - | - | [1] 18 18 💬
|
| 428 | DHEA tablet | - | - | - | - | [1] 86 86 💬
|
| 429 | DI-17E6 | - | - | - | - | [1] 51 51 💬
|
| 430 | DIACEREIN | [1] Diacerein Diacerein | [1] Diacerein
Diacerein
💬
| - | - | [3] 36 36, 46, 63 💬
|
| 431 | Diacerein 1% Ointment | [1] Diacerein Diacerein | [1] Diacerein
Diacerein
💬
| - | - | [1] 36 36 💬
|
| 432 | Diacerin cream | - | - | - | - | [1] 36 36 💬
|
| 433 | DIACOMIT | - | - | - | - | [1] 140 140 💬
|
| 434 | DIAG723 | - | - | - | - | [2] 86 86, 227 💬
|
| 435 | Diagnostic Imaging | - | - | - | - | [1] 60 60 💬
|
| 436 | Diagnostic Test: 1 hour ECG | - | - | - | - | [1] 19 19 💬
|
| 437 | Diagnostic Test: 11C-MC1 | - | - | - | - | [1] 46 46 💬
|
| 438 | Diagnostic Test: 11C-Methionine PET/CT | [1] Methionine Methionine | [1] Methionine
Methionine
💬
| - | - | [1] 75 75 💬
|
| 439 | Diagnostic Test: 11C-UCB-J PET-CT | - | - | - | - | [1] 8 8 💬
|
| 440 | Diagnostic Test: 12-Lead ECG | - | - | - | - | [1] 58 58 💬
|
| 441 | Diagnostic Test: 123I-MIBG | - | - | - | - | [1] 6 6 💬
|
| 442 | Diagnostic Test: 18F-FAPI-74 PET/CT Imaging | - | - | - | - | [1] 86 86 💬
|
| 443 | Diagnostic Test: 18F-FDG and 68Ga-FAPI PET/CT | - | - | - | - | [1] 96 96 💬
|
| 444 | Diagnostic Test: 18F-FDG PET-MR | - | - | - | - | [1] 8 8 💬
|
| 445 | Diagnostic Test: 18F-FDG-PET/MRI | - | - | - | - | [1] 84 84 💬
|
| 446 | Diagnostic Test: 18F-FGLN PET Imaging | - | - | - | - | [1] 86 86 💬
|
| 447 | Diagnostic Test: 18F-GE180-PET/MRI | - | - | - | - | [1] 84 84 💬
|
| 448 | Diagnostic Test: 24 hour copper in urine and liver function test | [1] Copper Copper | - | - | - | [1] 171 171 💬
|
| 449 | Diagnostic Test: 24 hour pulse wave analysis | - | - | - | - | [1] 19 19 💬
|
| 450 | Diagnostic Test: 24 hr urine samples | - | - | - | - | [1] 235 235 💬
|
| 451 | Diagnostic Test: 24-hour ambulatory blood pressure monitoring | - | - | - | - | [1] 48 48 💬
|
| 452 | Diagnostic Test: 24-hour blood pressure measurement | - | - | - | - | [1] 19 19 💬
|
| 453 | Diagnostic Test: 24-hour Urine test | - | - | - | - | [1] 75 75 💬
|
| 454 | Diagnostic Test: 3 Tesla MRI | - | - | - | - | [1] 127 127 💬
|
| 455 | Diagnostic Test: 3 Tesla MRI without contrast medium | - | - | - | - | [3] 2 2, 5, 127 💬
|
| 456 | Diagnostic Test: 3'mRNA sequencing | - | - | - | - | [1] 41 41 💬
|
| 457 | Diagnostic Test: 30 seconds sit to stand test | - | - | - | - | [1] 113 113 💬
|
| 458 | Diagnostic Test: 30:15 ratio | - | - | - | - | [1] 266 266 💬
|
| 459 | Diagnostic Test: 3D T1 MRI sequences injected with fat saturation and black blood | - | - | - | - | [1] 41 41 💬
|
| 460 | Diagnostic Test: 4 ml. of fresh venous blood will be collected from each patient on EDTA tube and will be used for detection of the following : T cell immunoglobulin G ( TIgG) and T cell immunoglobulin M (TIgM) by | - | - | - | - | [1] 49 49 💬
|
| 461 | Diagnostic Test: 48-hour ECG monitoring. | - | - | - | - | [1] 57 57 💬
|
| 462 | Diagnostic Test: 64Cu-DOTATATE PET/CT scan | [1] Dotatate Dotatate | - | - | - | [1] 84 84 💬
|
| 463 | Diagnostic Test: 68-Ga HA-DOTATATE PET/CT | [1] Dotatate Dotatate | - | - | - | [1] 41 41 💬
|
| 464 | Diagnostic Test: 68Ga-DOTA-TOC PET/CT | - | - | - | - | [1] 84 84 💬
|
| 465 | Diagnostic Test: 68Ga-DOTATATE PET/MRI | [1] Dotatate Dotatate | - | - | - | [1] 19 19 💬
|
| 466 | Diagnostic Test: 7-T MRI scan | - | - | - | - | [1] 13 13 💬
|
| 467 | Diagnostic Test: 72-hour fecal fat quantification | - | - | - | - | [1] 298 298 💬
|
| 468 | Diagnostic Test: 7T MRI scan | - | - | - | - | [3] 5 5, 7, 127 💬
|
| 469 | Diagnostic Test: 7T MRI-scan | - | - | - | - | [1] 8 8 💬
|
| 470 | Diagnostic Test: =Urine analysis =Urine protein quantification =Serum albumin =Lipid profile.Quantitation of miRNA -30a by Real-time polymerase chain reaction (Q-PCR) in peripheral blood. | - | - | - | - | [1] 222 222 💬
|
| 471 | Diagnostic Test: [123I] MIBG scintigraphy of the heart | - | - | - | - | [1] 6 6 💬
|
| 472 | Diagnostic Test: [18F]-RO6958948 | - | - | - | - | [6] 2 2, 5, 6, 7, 17, 127 💬
|
| 473 | Diagnostic Test: a-synuclein seeding amplification assays | - | - | - | - | [1] 6 6 💬
|
| 474 | Diagnostic Test: A. Routine .1CBC with blood film. .2Liver Function Test. .3Kidney Function Test. 4. Inflamatory marker ESR, CRP B.Immunology 1-Immunoglobulins IgG, IgM, IgA, IgE 2-Flow cytometric assessment: B | - | - | - | - | [1] 65 65 💬
|
| 475 | Diagnostic Test: Abdominal and liver ultrasound. | - | - | - | - | [1] 229 229 💬
|
| 476 | Diagnostic Test: Accelerometry to assess physical activity | - | - | - | - | [1] 299 299 💬
|
| 477 | Diagnostic Test: Actigraphy, blood and salivary sample, and sleep evaluation | - | - | - | - | [1] 134 134 💬
|
| 478 | Diagnostic Test: Adalimumab serum trough concentration | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 479 | Diagnostic Test: Adalimumab trough concentration | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 480 | Diagnostic Test: Addenbrooke's Cognitive Examination | - | - | - | - | [1] 127 127 💬
|
| 481 | Diagnostic Test: Adrenal aldosterone synthase (CYP11B2) staining | [1] Aldosterone Aldosterone | [1] Aldosterone
Aldosterone
💬
| [1] NR3C2 NR3C2 💬
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [1] 75 75 💬
|
| 482 | Diagnostic Test: Adrenal cortisol synthase (CYP11B1) staining | - | - | - | - | [1] 75 75 💬
|
| 483 | Diagnostic Test: Air venous plethysmography | - | - | - | - | [1] 58 58 💬
|
| 484 | Diagnostic Test: AliveCor KardiaMobile 6-Lead ECG | - | - | - | - | [1] 58 58 💬
|
| 485 | Diagnostic Test: Ambulatory blood pressure monitoring | - | - | - | - | [1] 19 19 💬
|
| 486 | Diagnostic Test: Analysis of blood and microbiome samples (stool, oral lavage) | - | - | - | - | [1] 41 41 💬
|
| 487 | Diagnostic Test: Analysis of prouroguanyline and uroguanyline in full blood | - | - | - | - | [1] 97 97 💬
|
| 488 | Diagnostic Test: Angio-Optical Coherence Tomography | - | - | - | - | [1] 41 41 💬
|
| 489 | Diagnostic Test: Angiotensin Converting Enzyme test | - | - | - | - | [1] 49 49 💬
|
| 490 | Diagnostic Test: Ankle-brachial pressure index (ABPI) | - | - | - | - | [1] 240 240 💬
|
| 491 | Diagnostic Test: Anthropometric Measurements | - | - | - | - | [1] 299 299 💬
|
| 492 | Diagnostic Test: Anti phospholipid marker | - | - | - | - | [1] 49 49 💬
|
| 493 | Diagnostic Test: anti-aquaporin-4 antibody | - | - | - | - | [1] 13 13 💬
|
| 494 | Diagnostic Test: Anti-CCP- and anti-P.g.-antibodies titers | - | - | - | - | [1] 46 46 💬
|
| 495 | Diagnostic Test: anti-myelin oligodendrocyte glycoprotein | - | - | - | - | [1] 13 13 💬
|
| 496 | Diagnostic Test: Antibodies to golimumab | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 497 | Diagnostic Test: Antinuclear Antibody tests (ANA) | - | - | - | - | [1] 49 49 💬
|
| 498 | Diagnostic Test: Antiphospholipid antibody profile | - | - | - | - | [1] 48 48 💬
|
| 499 | Diagnostic Test: Aortic/ cardiac magnetic resonance imaging | - | - | - | - | [1] 41 41 💬
|
| 500 | Diagnostic Test: Apple Smart Watch Single Lead ECG | [1] Apple Apple | - | - | - | [1] 58 58 💬
|
| 501 | Diagnostic Test: Arterial blood gas (ABG) | - | - | - | - | [1] 299 299 💬
|
| 502 | Diagnostic Test: Arterial blood gas analysis | - | - | - | - | [1] 2 2 💬
|
| 503 | Diagnostic Test: Assessment of arterial stiffness using the VaSera VS-1500N | - | - | - | - | [2] 89 89, 299 💬
|
| 504 | Diagnostic Test: Assessment of dynamic EEG features over 48-hour periods across all study aims | - | - | - | - | [1] 6 6 💬
|
| 505 | Diagnostic Test: ataxia score | - | - | - | - | [1] 65 65 💬
|
| 506 | Diagnostic Test: Audiology assessment with ABR | - | - | - | - | [1] 19 19 💬
|
| 507 | Diagnostic Test: Autonomic Function Testing | - | - | - | - | [1] 254 254 💬
|
| 508 | Diagnostic Test: AV1451 Tau | - | - | - | - | [1] 7 7 💬
|
| 509 | Diagnostic Test: Barium Esophagram | [1] Barium Barium | - | - | - | [1] 98 98 💬
|
| 510 | Diagnostic Test: Baseline blood sample | - | - | - | - | [1] 96 96 💬
|
| 511 | Diagnostic Test: Baseline blood tests | - | - | - | - | [1] 83 83 💬
|
| 512 | Diagnostic Test: Baseline intestinal biopsies | - | - | - | - | [1] 96 96 💬
|
| 513 | Diagnostic Test: Baseline stool sample | - | - | - | - | [1] 96 96 💬
|
| 514 | Diagnostic Test: Beam test to predict falls | - | - | - | - | [1] 6 6 💬
|
| 515 | Diagnostic Test: Beck depression inventory | - | - | - | - | [1] 113 113 💬
|
| 516 | Diagnostic Test: Beck depression inventory fast screen (Questionnaire) | - | - | - | - | [3] 3 3, 15, 256 💬
|
| 517 | Diagnostic Test: Berg balance scale | - | - | - | - | [1] 113 113 💬
|
| 518 | Diagnostic Test: BIA Sub-study | [1] BIA BIA | - | - | - | [1] 299 299 💬
|
| 519 | Diagnostic Test: Biochemistry and immune phenotyping | - | - | - | - | [1] 19 19 💬
|
| 520 | Diagnostic Test: bioelectrical impedance analysis | - | - | - | - | [2] 65 65, 172 💬
|
| 521 | Diagnostic Test: Bioimpedenziometry, Handgrip strenght evaluation | - | - | - | - | [1] 10 10 💬
|
| 522 | Diagnostic Test: Biomarker analysis of blood samples | - | - | - | - | [1] 56 56 💬
|
| 523 | Diagnostic Test: Biotherapy Prescription with SinnoTest® software | - | - | - | - | [1] 46 46 💬
|
| 524 | Diagnostic Test: Blood | - | - | - | - | [1] 96 96 💬
|
| 525 | Diagnostic Test: Blood analysis for hypercalcemia's control | - | - | - | - | [1] 18 18 💬
|
| 526 | Diagnostic Test: blood and CSF biomarker | - | - | - | - | [1] 7 7 💬
|
| 527 | Diagnostic Test: Blood and urine sample | - | - | - | - | [1] 72 72 💬
|
| 528 | Diagnostic Test: Blood and urine sampling | - | - | - | - | [1] 84 84 💬
|
| 529 | Diagnostic Test: blood biomarkers | - | - | - | - | [1] 96 96 💬
|
| 530 | Diagnostic Test: Blood collection | - | - | - | - | [1] 56 56 💬
|
| 531 | Diagnostic Test: Blood draw | - | - | - | - | [8] 34 34, 65, 85, 86, 96, 97, 240, 299 💬
|
| 532 | Diagnostic Test: Blood Draw - Baseline | - | - | - | - | [1] 18 18 💬
|
| 533 | Diagnostic Test: Blood Draw - Follow-up 12 months | - | - | - | - | [1] 18 18 💬
|
| 534 | Diagnostic Test: Blood Draw - Follow-up 24 months | - | - | - | - | [1] 18 18 💬
|
| 535 | Diagnostic Test: Blood draw for hematocrit and heart failure biomarkers | - | - | - | - | [1] 210 210 💬
|
| 536 | Diagnostic Test: Blood draw for the laboratory assessment | - | - | - | - | [1] 94 94 💬
|
| 537 | Diagnostic Test: blood drawing | - | - | - | - | [1] 21 21 💬
|
| 538 | Diagnostic Test: blood drawing in healthy controls | - | - | - | - | [1] 65 65 💬
|
| 539 | Diagnostic Test: blood drawing in patients with WAS | - | - | - | - | [1] 65 65 💬
|
| 540 | Diagnostic Test: Blood function test, liver function test, kidney function test, and immune function test | - | - | - | - | [1] 53 53 💬
|
| 541 | Diagnostic Test: Blood laboratory Testing | - | - | - | - | [1] 254 254 💬
|
| 542 | Diagnostic Test: blood pressure response to standing | - | - | - | - | [1] 266 266 💬
|
| 543 | Diagnostic Test: blood pressure response to sustained handgrip test | - | - | - | - | [1] 266 266 💬
|
| 544 | Diagnostic Test: Blood Routine Test at 12-week | - | - | - | - | [1] 97 97 💬
|
| 545 | Diagnostic Test: Blood Routine Test at 4-week | - | - | - | - | [1] 97 97 💬
|
| 546 | Diagnostic Test: Blood Routine Test at 8-week | - | - | - | - | [1] 97 97 💬
|
| 547 | Diagnostic Test: Blood sample | - | - | - | - | [7] 10 10, 13, 49, 85, 271, 298, 299 💬
|
| 548 | Diagnostic Test: Blood sample and urine collection | - | - | - | - | [1] 235 235 💬
|
| 549 | Diagnostic Test: Blood sample collection | - | - | - | - | [2] 19 19, 20 💬
|
| 550 | Diagnostic Test: Blood sample collection for coagulation profile | - | - | - | - | [1] 13 13 💬
|
| 551 | Diagnostic Test: Blood sample collection for VWF measurements in plasma | - | - | - | - | [1] 288 288 💬
|
| 552 | Diagnostic Test: blood sample test | - | - | - | - | [1] 298 298 💬
|
| 553 | Diagnostic Test: blood sample, cerebrospinal fluid (optional) | - | - | - | - | [1] 17 17 💬
|
| 554 | Diagnostic Test: Blood samples | - | - | - | - | [4] 6 6, 49, 56, 235 💬
|
| 555 | Diagnostic Test: Blood samples analysis. | - | - | - | - | [1] 57 57 💬
|
| 556 | Diagnostic Test: Blood samples and processing | - | - | - | - | [1] 13 13 💬
|
| 557 | Diagnostic Test: Blood samples for sNfL and sGFAP levels | - | - | - | - | [1] 13 13 💬
|
| 558 | Diagnostic Test: Blood sampling | - | - | - | - | [8] 49 49, 51, 65, 74, 97, 127, 231, 299 💬
|
| 559 | Diagnostic Test: blood sampling (alpha-Galactosidase & LysoGb3) | - | - | - | - | [2] 19 19, 58 💬
|
| 560 | Diagnostic Test: Blood Test | - | - | - | - | [5] 48 48, 51, 75, 298, 300 💬
|
| 561 | Diagnostic Test: Blood test - EBV serology | - | - | - | - | [1] 13 13 💬
|
| 562 | Diagnostic Test: Blood test - Neurofilament light chain (NfL) | - | - | - | - | [1] 13 13 💬
|
| 563 | Diagnostic Test: Blood test and clinical examination. | - | - | - | - | [1] 6 6 💬
|
| 564 | Diagnostic Test: blood test for pro-inflammatory cytokines and ultrasound of the median nerves | - | - | - | - | [1] 10 10 💬
|
| 565 | Diagnostic Test: blood tests drawn days 1, 8, 22 and 90 of the study | - | - | - | - | [1] 13 13 💬
|
| 566 | Diagnostic Test: Blood withdrawal | - | - | - | - | [4] 5 5, 7, 8, 127 💬
|
| 567 | Diagnostic Test: BlyS | - | - | - | - | [1] 64 64 💬
|
| 568 | Diagnostic Test: BMI and lean mass index from DXA | - | - | - | - | [1] 299 299 💬
|
| 569 | Diagnostic Test: Body composition using a hand-held body fat monitor • Resting Metabolic Rate (RMR) using a ventilated hood system | - | - | - | - | [1] 8 8 💬
|
| 570 | Diagnostic Test: Bone density scan (DEXA) | - | - | - | - | [1] 19 19 💬
|
| 571 | Diagnostic Test: Bone Mineral Density (DEXA) scan | - | - | - | - | [1] 98 98 💬
|
| 572 | Diagnostic Test: Borg Scale | - | - | - | - | [3] 3 3, 15, 256 💬
|
| 573 | Diagnostic Test: brain imaging | - | - | - | - | [1] 6 6 💬
|
| 574 | Diagnostic Test: Brain Magnetic Resonance | - | - | - | - | [2] 57 57, 58 💬
|
| 575 | Diagnostic Test: Brain MRI | - | - | - | - | [2] 25 25, 229 💬
|
| 576 | Diagnostic Test: Breath test using the Compact PTR-TOF-MS | - | - | - | - | [2] 89 89, 299 💬
|
| 577 | Diagnostic Test: Brief Pain Inventory (BPI) (Questionnaire) | - | - | - | - | [3] 3 3, 15, 256 💬
|
| 578 | Diagnostic Test: Brief Pain Inventory Short-Form | - | - | - | - | [1] 113 113 💬
|
| 579 | Diagnostic Test: Buccal Swabs and Blood Draws | - | - | - | - | [1] 18 18 💬
|
| 580 | Diagnostic Test: Buccal Swabs, Blood Draws and Skin Punch Biopsy | - | - | - | - | [1] 18 18 💬
|
| 581 | Diagnostic Test: Bulbar Function Questionnaires | - | - | - | - | [1] 111 111 💬
|
| 582 | Diagnostic Test: C reactive protein | - | - | - | - | [1] 46 46 💬
|
| 583 | Diagnostic Test: C-11 ER176 Radiotracer | - | - | - | - | [1] 7 7 💬
|
| 584 | Diagnostic Test: C-11 PiB | - | - | - | - | [1] 7 7 💬
|
| 585 | Diagnostic Test: C-reactive protein (CRP) | - | - | - | - | [1] 97 97 💬
|
| 586 | Diagnostic Test: C-reactive Protein Test at 12-week | - | - | - | - | [1] 97 97 💬
|
| 587 | Diagnostic Test: C-reactive Protein Test at 4-week | - | - | - | - | [1] 97 97 💬
|
| 588 | Diagnostic Test: C-reactive Protein Test at 8-week | - | - | - | - | [1] 97 97 💬
|
| 589 | Diagnostic Test: C3 and C4 complement level. | - | - | - | - | [1] 49 49 💬
|
| 590 | Diagnostic Test: C5a | - | - | - | - | [1] 64 64 💬
|
| 591 | Diagnostic Test: Calculation of PLR: Platelet count / Lymphocyte count and Calculation of NLR: | - | - | - | - | [1] 48 48 💬
|
| 592 | Diagnostic Test: Calprotectin | - | - | - | - | [1] 97 97 💬
|
| 593 | Diagnostic Test: Candy Glucose Tolerance Test | - | - | - | - | [1] 299 299 💬
|
| 594 | Diagnostic Test: Capillary CO2 (CapCO2) | - | - | - | - | [1] 299 299 💬
|
| 595 | Diagnostic Test: Cardiac Magnetic Resonance | - | - | - | - | [2] 57 57, 58 💬
|
| 596 | Diagnostic Test: Cardiac Magnetic Resonance Imaging | - | - | - | - | [1] 210 210 💬
|
| 597 | Diagnostic Test: Cardiac MRI | - | - | - | - | [1] 113 113 💬
|
| 598 | Diagnostic Test: Cardiac MRI (Gadolinium enhanced) | [1] Gadolinium Gadolinium | - | - | - | [1] 86 86 💬
|
| 599 | Diagnostic Test: Cardiac MRI, ECG/Holter and Blood Biomarkers | - | - | - | - | [1] 19 19 💬
|
| 600 | Diagnostic Test: Cardio MRI | - | - | - | - | [1] 19 19 💬
|
| 601 | Diagnostic Test: Cardiopulmonary exercise test | - | - | - | - | [1] 210 210 💬
|
| 602 | Diagnostic Test: Cardiopulmonary Exercise Testing | - | - | - | - | [1] 21 21 💬
|
| 603 | Diagnostic Test: Cardiopulmonary exercise testing (CPET) | - | - | - | - | [1] 19 19 💬
|
| 604 | Diagnostic Test: Carotid intima media thickness measurement (CIMT) | - | - | - | - | [1] 240 240 💬
|
| 605 | Diagnostic Test: Carotid Ultrasound | - | - | - | - | [2] 46 46, 49 💬
|
| 606 | Diagnostic Test: Carotid Ultrasound and venous blood sampling | - | - | - | - | [1] 52 52 💬
|
| 607 | Diagnostic Test: CBC | - | - | - | - | [1] 49 49 💬
|
| 608 | Diagnostic Test: Cell-based ex-vivo assay with high-content analysis | - | - | - | - | [1] 41 41 💬
|
| 609 | Diagnostic Test: Cerebrospinal and Blood Serum Semaphorin 4A Levels | - | - | - | - | [1] 13 13 💬
|
| 610 | Diagnostic Test: Cerebrospinal fluid sampling (CSF) | - | - | - | - | [3] 2 2, 5, 127 💬
|
| 611 | Diagnostic Test: Chest CT scans (When available within the past 6 months in medical records) | - | - | - | - | [1] 299 299 💬
|
| 612 | Diagnostic Test: Clinical Global Impression (CGI) | - | - | - | - | [1] 111 111 💬
|
| 613 | Diagnostic Test: Clinical laboratory evaluations - Biochemistry | - | - | - | - | [1] 49 49 💬
|
| 614 | Diagnostic Test: Clinical laboratory evaluations - Hematology | - | - | - | - | [1] 49 49 💬
|
| 615 | Diagnostic Test: Clinical laboratory evaluations - Serology | - | - | - | - | [1] 49 49 💬
|
| 616 | Diagnostic Test: Clinical measures | - | - | - | - | [4] 5 5, 7, 8, 127 💬
|
| 617 | Diagnostic Test: Clinical Scales - Baseline | - | - | - | - | [1] 18 18 💬
|
| 618 | Diagnostic Test: Clinical Scales - Follow-up 12 months | - | - | - | - | [1] 18 18 💬
|
| 619 | Diagnostic Test: Clinical Scales - Follow-up 24 months | - | - | - | - | [1] 18 18 💬
|
| 620 | Diagnostic Test: clobetasol decreasing measurement | [1] Clobetasol Clobetasol | [1] Clobetasol
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬
|
| 621 | Diagnostic Test: CMRI | - | - | - | - | [2] 51 51, 86 💬
|
| 622 | Diagnostic Test: Coagulation blood test | - | - | - | - | [2] 57 57, 58 💬
|
| 623 | Diagnostic Test: Cognitive Battery | - | - | - | - | [1] 6 6 💬
|
| 624 | Diagnostic Test: colchicine level measurement | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [1] 266 266 💬
|
| 625 | Diagnostic Test: collection of expectoration, stools and blood | - | - | - | - | [1] 299 299 💬
|
| 626 | Diagnostic Test: Colonoscopy | - | - | - | - | [1] 97 97 💬
|
| 627 | Diagnostic Test: Color Fundus Photography | - | - | - | - | [1] 41 41 💬
|
| 628 | Diagnostic Test: Companion diagnostic ( CDx) | - | - | - | - | [1] 51 51 💬
|
| 629 | Diagnostic Test: Complement C3d test (blood sample) | - | - | - | - | [1] 271 271 💬
|
| 630 | Diagnostic Test: Complete Blood Count | - | - | - | - | [2] 97 97, 107 💬
|
| 631 | Diagnostic Test: complete blood count (CBC) | - | - | - | - | [1] 97 97 💬
|
| 632 | Diagnostic Test: Complete blood count CBC | - | - | - | - | [1] 46 46 💬
|
| 633 | Diagnostic Test: complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-?. | - | - | - | - | [1] 63 63 💬
|
| 634 | Diagnostic Test: complete blood picture | - | - | - | - | [1] 63 63 💬
|
| 635 | Diagnostic Test: Composite Autonomic Symptom Score-31 | - | - | - | - | [1] 266 266 💬
|
| 636 | Diagnostic Test: computer vision, remote monitoring, blood, urine, wrist bands, mobile-app | - | - | - | - | [1] 8 8 💬
|
| 637 | Diagnostic Test: computerized dynamic posturography | - | - | - | - | [1] 6 6 💬
|
| 638 | Diagnostic Test: Continuous glucose monitoring | - | - | - | - | [1] 299 299 💬
|
| 639 | Diagnostic Test: Contrast-Enhanced Ultrasound | - | - | - | - | [1] 41 41 💬
|
| 640 | Diagnostic Test: Coronal T1 weighted spin echo images | - | - | - | - | [2] 96 96, 97 💬
|
| 641 | Diagnostic Test: Cortisol level | - | - | - | - | [1] 98 98 💬
|
| 642 | Diagnostic Test: Cosyntropin stimulation test | - | - | - | - | [1] 83 83 💬
|
| 643 | Diagnostic Test: Creatine Chemical Exchange Saturation Transfer (CrCEST) Imaging Sequence | [1] Creatine Creatine | - | - | - | [1] 21 21 💬
|
| 644 | Diagnostic Test: CRQ | - | - | - | - | [1] 46 46 💬
|
| 645 | Diagnostic Test: CSF | - | - | - | - | [3] 5 5, 7, 127 💬
|
| 646 | Diagnostic Test: CSF collection via lumbar puncture | - | - | - | - | [1] 8 8 💬
|
| 647 | Diagnostic Test: Cytokine | - | - | - | - | [1] 53 53 💬
|
| 648 | Diagnostic Test: Cytokines and chemokine profiling | - | - | - | - | [1] 49 49 💬
|
| 649 | Diagnostic Test: DAT-SPECT | - | - | - | - | [1] 17 17 💬
|
| 650 | Diagnostic Test: Deamino Arginine Vasopressin (dDAVP) | [2] Arginine Arginine, Vasopressin | [4] Vasopressin
Vasopressin
,
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| [3] AVPR1A AVPR1A, AVPR1B, AVPR2 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | [1] 225 225 💬
|
| 651 | Diagnostic Test: Deep Phenotyping | - | - | - | - | [1] 2 2 💬
|
| 652 | Diagnostic Test: Dental panoramic X-ray | - | - | - | - | [1] 46 46 💬
|
| 653 | Diagnostic Test: Depression screening | - | - | - | - | [1] 127 127 💬
|
| 654 | Diagnostic Test: Dexa scan | - | - | - | - | [1] 299 299 💬
|
| 655 | Diagnostic Test: Dexamethasone suppression test | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 75 75 💬
|
| 656 | Diagnostic Test: Dexamethasone test | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 75 75 💬
|
| 657 | Diagnostic Test: Diagnostic Test | - | - | - | - | [1] 265 265 💬
|
| 658 | Diagnostic Test: Digital lung sounds auscultation | - | - | - | - | [1] 85 85 💬
|
| 659 | Diagnostic Test: Disease activity | - | - | - | - | [1] 46 46 💬
|
| 660 | Diagnostic Test: Disease phenotyping | - | - | - | - | [1] 282 282 💬
|
| 661 | Diagnostic Test: DM1-ActivC | - | - | - | - | [1] 113 113 💬
|
| 662 | Diagnostic Test: DNA Exome sequencing | - | - | - | - | [1] 53 53 💬
|
| 663 | Diagnostic Test: Dobutamine stress echocardiography | [1] Dobutamine Dobutamine | [3] Dobutamine hydrochloride
Dobutamine hydrochloride
,
Dobutamine
,
Dobutamine tartrate
💬
| [1] ADRB1 ADRB1 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 28 28 💬
|
| 664 | Diagnostic Test: Dopamine transporter PET scan with [18F]FE-PE2I | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 665 | Diagnostic Test: Doppler echocardiogram exam | - | - | - | - | [2] 57 57, 58 💬
|
| 666 | Diagnostic Test: dosage of blood biomarker miR1 | - | - | - | - | [1] 113 113 💬
|
| 667 | Diagnostic Test: Dried Blood Spot Cards. | - | - | - | - | [1] 240 240 💬
|
| 668 | Diagnostic Test: Dry blood spot screening | - | - | - | - | [1] 296 296 💬
|
| 669 | Diagnostic Test: dry blood test | - | - | - | - | [2] 19 19, 97 💬
|
| 670 | Diagnostic Test: DXA | - | - | - | - | [1] 299 299 💬
|
| 671 | Diagnostic Test: Dynamic retinal vessel analysis (DVA) | - | - | - | - | [1] 19 19 💬
|
| 672 | Diagnostic Test: Early adoption of blood-based biomarkers for Alzheimer's disease | - | - | - | - | [1] 127 127 💬
|
| 673 | Diagnostic Test: Echocardiogram | - | - | - | - | [2] 19 19, 86 💬
|
| 674 | Diagnostic Test: Echocardiography | - | - | - | - | [2] 19 19, 58 💬
|
| 675 | Diagnostic Test: Echocardiography at M24 | - | - | - | - | [1] 19 19 💬
|
| 676 | Diagnostic Test: Echocardiography at T0 | - | - | - | - | [1] 19 19 💬
|
| 677 | Diagnostic Test: Echocardiography images | - | - | - | - | [1] 48 48 💬
|
| 678 | Diagnostic Test: Echocardiography with speckle tracking analysis. | - | - | - | - | [1] 57 57 💬
|
| 679 | Diagnostic Test: Elecsys (Roche) Abeta42, Ttau and Ptau | - | - | - | - | [6] 2 2, 5, 6, 7, 17, 127 💬
|
| 680 | Diagnostic Test: Electrocardiogram | - | - | - | - | [2] 49 49, 58 💬
|
| 681 | Diagnostic Test: Electrocardiogram (EKG) | - | - | - | - | [1] 19 19 💬
|
| 682 | Diagnostic Test: Electroencephalogram | - | - | - | - | [2] 6 6, 127 💬
|
| 683 | Diagnostic Test: electromyography | - | - | - | - | [2] 2 2, 6 💬
|
| 684 | Diagnostic Test: Endogenous thrombin potential | [1] Thrombin Thrombin | [1] Thrombin
Thrombin
💬
| - | - | [2] 86 86, 88 💬
|
| 685 | Diagnostic Test: Endoscopy while on study drug | - | - | - | - | [1] 98 98 💬
|
| 686 | Diagnostic Test: Entire-body PET-CT scans | - | - | - | - | [1] 13 13 💬
|
| 687 | Diagnostic Test: Enzyme-linked immunosorbent assay | - | - | - | - | [1] 41 41 💬
|
| 688 | Diagnostic Test: erythrocyte sedimentation rate (ESR) | - | - | - | - | [1] 97 97 💬
|
| 689 | Diagnostic Test: Erythrocyte sedimentation rate (ESR). | - | - | - | - | [1] 46 46 💬
|
| 690 | Diagnostic Test: Erythrocyte Sedimentation Rate Test at 12-week | - | - | - | - | [1] 97 97 💬
|
| 691 | Diagnostic Test: Erythrocyte Sedimentation Rate Test at 4-week | - | - | - | - | [1] 97 97 💬
|
| 692 | Diagnostic Test: Erythrocyte Sedimentation Rate Test at 8-week | - | - | - | - | [1] 97 97 💬
|
| 693 | Diagnostic Test: esophagogastroduodenoscopy (EGD), buccal swab, blood withdrawal | - | - | - | - | [1] 98 98 💬
|
| 694 | Diagnostic Test: estimation of serum level of IL17 | - | - | - | - | [1] 63 63 💬
|
| 695 | Diagnostic Test: estimation of serum level of IL2 | - | - | - | - | [1] 63 63 💬
|
| 696 | Diagnostic Test: evaluation of thrombus formation with Total Thrombus formation Analysis System (T-TAS) | - | - | - | - | [1] 64 64 💬
|
| 697 | Diagnostic Test: Evaluation on blood specimens | - | - | - | - | [1] 10 10 💬
|
| 698 | Diagnostic Test: Ewing's tests | - | - | - | - | [1] 6 6 💬
|
| 699 | Diagnostic Test: Examination of vibration perception threshold in fingertips | - | - | - | - | [1] 6 6 💬
|
| 700 | Diagnostic Test: Exercise Stress Transthoracic Echocardiogram | - | - | - | - | [1] 58 58 💬
|
| 701 | Diagnostic Test: Exercise test | - | - | - | - | [1] 19 19 💬
|
| 702 | Diagnostic Test: Exhalomics | - | - | - | - | [1] 210 210 💬
|
| 703 | Diagnostic Test: Extended laboratory diagnostics | - | - | - | - | [1] 172 172 💬
|
| 704 | Diagnostic Test: F1+2 | - | - | - | - | [1] 64 64 💬
|
| 705 | Diagnostic Test: Factor VIII (FVIII) | - | - | - | - | [1] 64 64 💬
|
| 706 | Diagnostic Test: fasting blood suger | - | - | - | - | [1] 49 49 💬
|
| 707 | Diagnostic Test: Fatigue and Daytime Sleepiness Scale | - | - | - | - | [1] 113 113 💬
|
| 708 | Diagnostic Test: Fatigue Severity and Disability Scale (FSS) (Questionnaire) | - | - | - | - | [3] 3 3, 15, 256 💬
|
| 709 | Diagnostic Test: FDG-PET | - | - | - | - | [1] 6 6 💬
|
| 710 | Diagnostic Test: FDG-PET/CT with Rb82 Myocardial Perfusion Imaging | - | - | - | - | [1] 84 84 💬
|
| 711 | Diagnostic Test: Fecal and blood samples | - | - | - | - | [1] 166 166 💬
|
| 712 | Diagnostic Test: Fecal Calprotectin | - | - | - | - | [1] 97 97 💬
|
| 713 | Diagnostic Test: fecal elastase-1 test | - | - | - | - | [1] 298 298 💬
|
| 714 | Diagnostic Test: Fecal microbiome probiotic | - | - | - | - | [1] 294 294 💬
|
| 715 | Diagnostic Test: fibrinogen plasma concentration, coagulation factor XIII activity | - | - | - | - | [1] 288 288 💬
|
| 716 | Diagnostic Test: fibrinogen to albumin ratio (AFR) and C-reactive protein to albumin ratio (CAR) | - | - | - | - | [1] 107 107 💬
|
| 717 | Diagnostic Test: Fibrinogen to albumin Ratio and C-reactive to Albumin Ratio | - | - | - | - | [1] 49 49 💬
|
| 718 | Diagnostic Test: Fibromyalgia rapid screening tool | - | - | - | - | [1] 266 266 💬
|
| 719 | Diagnostic Test: Five-Times-Sit-to-Stand Test | - | - | - | - | [1] 65 65 💬
|
| 720 | Diagnostic Test: Flow cytometry | - | - | - | - | [1] 41 41 💬
|
| 721 | Diagnostic Test: Fluorescein and Indocyanine green Angiography | [3] Fluorescein Fluorescein, Indocyanine green, Indocyanine green acid form | [3] Fluorescein
Fluorescein
,
Indocyanine green
,
Fluorescein sodium
💬
| - | - | [1] 41 41 💬
|
| 722 | Diagnostic Test: Fluorescein angiography | [1] Fluorescein Fluorescein | [2] Fluorescein
Fluorescein
,
Fluorescein sodium
💬
| - | - | [1] 41 41 💬
|
| 723 | Diagnostic Test: Fluoro[18F]promethazine | [1] Promethazine Promethazine | [3] Promethazine hydrochloride
Promethazine hydrochloride
,
Promethazine
,
Promethazine teoclate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 6 6 💬
|
| 724 | Diagnostic Test: Flutemetamol F18 Injection | [1] Flutemetamol Flutemetamol | - | - | - | [6] 2 2, 5, 6, 7, 17, 127 💬
|
| 725 | Diagnostic Test: functional and antigenic C1 inhibitor | - | - | - | - | [1] 65 65 💬
|
| 726 | Diagnostic Test: Functional assessment questionnaires | - | - | - | - | [1] 41 41 💬
|
| 727 | Diagnostic Test: Functional Index-2 | - | - | - | - | [1] 113 113 💬
|
| 728 | Diagnostic Test: Functional magnetic resonance imaging - Blood Oxygenation Level Dependent | - | - | - | - | [1] 294 294 💬
|
| 729 | Diagnostic Test: Functional residual capacity | - | - | - | - | [1] 294 294 💬
|
| 730 | Diagnostic Test: Fundus autofluorescence | - | - | - | - | [1] 41 41 💬
|
| 731 | Diagnostic Test: GABA Blood Level | - | - | - | - | [1] 140 140 💬
|
| 732 | Diagnostic Test: gait analysis | - | - | - | - | [1] 149 149 💬
|
| 733 | Diagnostic Test: Gastrointestinal Quality of Life index | - | - | - | - | [1] 98 98 💬
|
| 734 | Diagnostic Test: Gated MRI scan | - | - | - | - | [1] 75 75 💬
|
| 735 | Diagnostic Test: genetic sequencing | - | - | - | - | [1] 298 298 💬
|
| 736 | Diagnostic Test: Genetic Testing | - | - | - | - | [1] 254 254 💬
|
| 737 | Diagnostic Test: Genetic testing of the alkaline phosphatase gene | [1] Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [1] 172 172 💬
|
| 738 | Diagnostic Test: Genotyping | - | - | - | - | [1] 299 299 💬
|
| 739 | Diagnostic Test: German Pain Inventory (Questionnaire) | - | - | - | - | [3] 3 3, 15, 256 💬
|
| 740 | Diagnostic Test: GFAP | - | - | - | - | [1] 64 64 💬
|
| 741 | Diagnostic Test: Golimumab trough levels | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 742 | Diagnostic Test: Gonadorelin acetate and Triptorelin acetate | [3] Acetate Acetate, Gonadorelin, Triptorelin | [6] Gonadorelin hydrochloride
Gonadorelin hydrochloride
,
Gonadorelin acetate
,
Triptorelin
,
Triptorelin pamoate
,
Gonadorelin
,
Triptorelin acetate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
| 743 | Diagnostic Test: Grip strength test | - | - | - | - | [1] 86 86 💬
|
| 744 | Diagnostic Test: growth hormone level and insulin like growth factor 1 | - | - | - | - | [1] 36 36 💬
|
| 745 | Diagnostic Test: GSGC | - | - | - | - | [1] 113 113 💬
|
| 746 | Diagnostic Test: Hand opening time | - | - | - | - | [1] 113 113 💬
|
| 747 | Diagnostic Test: Hand-grip strength | - | - | - | - | [1] 299 299 💬
|
| 748 | Diagnostic Test: Handheld Dynamometry (HHD) | - | - | - | - | [3] 3 3, 15, 256 💬
|
| 749 | Diagnostic Test: Hearing assessment | - | - | - | - | [1] 122 122 💬
|
| 750 | Diagnostic Test: Heart rate variability | - | - | - | - | [1] 53 53 💬
|
| 751 | Diagnostic Test: Height measurement | - | - | - | - | [1] 98 98 💬
|
| 752 | Diagnostic Test: High resolution Computed Tomography (HRCT) scans of the Chest | - | - | - | - | [1] 85 85 💬
|
| 753 | Diagnostic Test: High-resolution manometry | - | - | - | - | [1] 98 98 💬
|
| 754 | Diagnostic Test: High-resolution Optical Coherence Tomography | - | - | - | - | [1] 41 41 💬
|
| 755 | Diagnostic Test: Histology | - | - | - | - | [1] 97 97 💬
|
| 756 | Diagnostic Test: Histopathological analysis | - | - | - | - | [1] 75 75 💬
|
| 757 | Diagnostic Test: Hologic Dual X-Ray Absorptiometry (DXA) | - | - | - | - | [1] 299 299 💬
|
| 758 | Diagnostic Test: Holter ECG | - | - | - | - | [1] 58 58 💬
|
| 759 | Diagnostic Test: Holter monitoring | - | - | - | - | [2] 57 57, 58 💬
|
| 760 | Diagnostic Test: HRCT | - | - | - | - | [2] 51 51, 85 💬
|
| 761 | Diagnostic Test: Hyperpolarized 13C-Pyruvate | - | - | - | - | [3] 57 57, 84, 113 💬
|
| 762 | Diagnostic Test: ICAM | - | - | - | - | [1] 64 64 💬
|
| 763 | Diagnostic Test: IL-1beta | - | - | - | - | [1] 64 64 💬
|
| 764 | Diagnostic Test: IL-1ß | - | - | - | - | [1] 64 64 💬
|
| 765 | Diagnostic Test: IL-6 | - | - | - | - | [1] 64 64 💬
|
| 766 | Diagnostic Test: Imaging | - | - | - | - | [3] 51 51, 94, 96 💬
|
| 767 | Diagnostic Test: Imaging and fluid biomarkers | - | - | - | - | [1] 171 171 💬
|
| 768 | Diagnostic Test: Imaging assessment | - | - | - | - | [1] 48 48 💬
|
| 769 | Diagnostic Test: Imaging, blood samples, fuctional tests and physical examination | - | - | - | - | [1] 51 51 💬
|
| 770 | Diagnostic Test: Immunohistochemistry of Temporal Artery Biopsies | - | - | - | - | [1] 41 41 💬
|
| 771 | Diagnostic Test: Inborn errors of immunity | - | - | - | - | [1] 65 65 💬
|
| 772 | Diagnostic Test: Induced Sputum | - | - | - | - | [1] 299 299 💬
|
| 773 | Diagnostic Test: Inertial measurement Unite | - | - | - | - | [1] 6 6 💬
|
| 774 | Diagnostic Test: Infliximab level analysis in biological samples | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 775 | Diagnostic Test: Information Collected as Standard of Care | - | - | - | - | [1] 46 46 💬
|
| 776 | Diagnostic Test: initial fecal microbiome | - | - | - | - | [1] 294 294 💬
|
| 777 | Diagnostic Test: initial pulmonary microbiome | - | - | - | - | [1] 294 294 💬
|
| 778 | Diagnostic Test: initial VOC | - | - | - | - | [1] 294 294 💬
|
| 779 | Diagnostic Test: Injected abdominal CT | - | - | - | - | [1] 299 299 💬
|
| 780 | Diagnostic Test: interferon gamma releasing assay (IGRA) | [1] Interferon Gamma Interferon Gamma | - | - | - | [1] 96 96 💬
|
| 781 | Diagnostic Test: Iontophoresis sessions in forearm of subjects with pilocarpine | [1] Pilocarpine Pilocarpine | [3] Pilocarpine
Pilocarpine
,
Pilocarpine hydrochloride
,
Pilocarpine nitrate
💬
| [2] CHRM2 CHRM2, CHRM3 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 782 | Diagnostic Test: Iron status testing | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 783 | Diagnostic Test: Kidney Function Test at 12-week | - | - | - | - | [1] 97 97 💬
|
| 784 | Diagnostic Test: Kidney Function Test at 4-week | - | - | - | - | [1] 97 97 💬
|
| 785 | Diagnostic Test: Kidney Function Test at 8-week | - | - | - | - | [1] 97 97 💬
|
| 786 | Diagnostic Test: Laboratory assessment: | - | - | - | - | [1] 41 41 💬
|
| 787 | Diagnostic Test: Laboratory assessment: calcium | [1] Calcium Calcium | - | - | - | [3] 3 3, 15, 256 💬
|
| 788 | Diagnostic Test: Laboratory assessment: Creatine kinase | [1] Creatine Creatine | - | - | - | [3] 3 3, 15, 256 💬
|
| 789 | Diagnostic Test: Laboratory assessment: magnesium | [1] Magnesium Magnesium | - | - | - | [3] 3 3, 15, 256 💬
|
| 790 | Diagnostic Test: Laboratory assessment: phosphate | - | - | - | - | [3] 3 3, 15, 256 💬
|
| 791 | Diagnostic Test: Laboratory assessment: Vitamin D Level | [1] Vitamin D Vitamin D | - | - | - | [3] 3 3, 15, 256 💬
|
| 792 | Diagnostic Test: Laboratory Assessments | - | - | - | - | [1] 85 85 💬
|
| 793 | Diagnostic Test: laboratory experiments before and after mepolizumab treatment | [1] Mepolizumab Mepolizumab | [1] Mepolizumab
Mepolizumab
💬
| [1] IL5 IL5 💬
| [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [2] 44 44, 45 💬
|
| 794 | Diagnostic Test: Laboratory test | - | - | - | - | [1] 63 63 💬
|
| 795 | Diagnostic Test: Laboratory testing | - | - | - | - | [3] 84 84, 97, 271 💬
|
| 796 | Diagnostic Test: Laboratory tests | - | - | - | - | [1] 19 19 💬
|
| 797 | Diagnostic Test: Lactate dehydrogenase | - | - | - | - | [1] 63 63 💬
|
| 798 | Diagnostic Test: Leucine-rich a2-glycoprotein | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [2] 96 96, 97 💬
|
| 799 | Diagnostic Test: Light transmission aggregometry | - | - | - | - | [2] 86 86, 88 💬
|
| 800 | Diagnostic Test: Lipid analysis | - | - | - | - | [1] 79 79 💬
|
| 801 | Diagnostic Test: lipid profile | - | - | - | - | [1] 49 49 💬
|
| 802 | Diagnostic Test: lipid profile test | - | - | - | - | [1] 46 46 💬
|
| 803 | Diagnostic Test: Liver Function Test at 12-week | - | - | - | - | [1] 97 97 💬
|
| 804 | Diagnostic Test: Liver Function Test at 4-week | - | - | - | - | [1] 97 97 💬
|
| 805 | Diagnostic Test: Liver Function Test at 8-week | - | - | - | - | [1] 97 97 💬
|
| 806 | Diagnostic Test: Lumbar Puncture for analysis of Cerebrospinal Fluid | - | - | - | - | [1] 2 2 💬
|
| 807 | Diagnostic Test: Lumipulse (Fujirebio) Abeta42, Ttau and Ptau | - | - | - | - | [6] 2 2, 5, 6, 7, 17, 127 💬
|
| 808 | Diagnostic Test: Lung function | - | - | - | - | [1] 299 299 💬
|
| 809 | Diagnostic Test: magnetic resonance imaging | - | - | - | - | [3] 7 7, 46, 344 💬
|
| 810 | Diagnostic Test: Magnetic resonance imaging (MRI) | - | - | - | - | [1] 6 6 💬
|
| 811 | Diagnostic Test: Magnetic Resonance Imaging and an optional blood test | - | - | - | - | [1] 65 65 💬
|
| 812 | Diagnostic Test: Magnetic resonance relaxometry | - | - | - | - | [1] 299 299 💬
|
| 813 | Diagnostic Test: Magnetic resonance spectroscopy | - | - | - | - | [3] 96 96, 97, 299 💬
|
| 814 | Diagnostic Test: Manual muscle testing | - | - | - | - | [1] 113 113 💬
|
| 815 | Diagnostic Test: Maximum oxygen uptake | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 294 294 💬
|
| 816 | Diagnostic Test: MBT 2 | - | - | - | - | [1] 298 298 💬
|
| 817 | Diagnostic Test: MBT1 | - | - | - | - | [1] 298 298 💬
|
| 818 | Diagnostic Test: McGill pain questionnaire | - | - | - | - | [1] 113 113 💬
|
| 819 | Diagnostic Test: Measurement of serum level of anti-dementia drug | - | - | - | - | [1] 6 6 💬
|
| 820 | Diagnostic Test: Measures of arterial stiffness and endothelial function | - | - | - | - | [1] 19 19 💬
|
| 821 | Diagnostic Test: Methionine/homocysteine Dosage | [2] Homocysteine Homocysteine, Methionine | [1] Methionine
Methionine
💬
| - | - | [1] 229 229 💬
|
| 822 | Diagnostic Test: Microbiology | - | - | - | - | [1] 299 299 💬
|
| 823 | Diagnostic Test: Microfluidic Flow Chamber | - | - | - | - | [1] 64 64 💬
|
| 824 | Diagnostic Test: Mini-mental State Examination | - | - | - | - | [1] 127 127 💬
|
| 825 | Diagnostic Test: Molecular Diagnosis | - | - | - | - | [1] 18 18 💬
|
| 826 | Diagnostic Test: Motion Capture system | - | - | - | - | [1] 6 6 💬
|
| 827 | Diagnostic Test: Motor Function Assessments | - | - | - | - | [1] 111 111 💬
|
| 828 | Diagnostic Test: Motor function scales | - | - | - | - | [2] 111 111, 113 💬
|
| 829 | Diagnostic Test: MRI | - | - | - | - | [3] 13 13, 51, 127 💬
|
| 830 | Diagnostic Test: MRI acquisition | - | - | - | - | [1] 17 17 💬
|
| 831 | Diagnostic Test: MRI Brain and Cervical Spine | - | - | - | - | [1] 13 13 💬
|
| 832 | Diagnostic Test: MRI imaging | - | - | - | - | [1] 96 96 💬
|
| 833 | Diagnostic Test: MRI scans | - | - | - | - | [1] 235 235 💬
|
| 834 | Diagnostic Test: MRI using a hepatobiliary phase contrast agent (Gd-EOB-DPTA) | - | - | - | - | [1] 94 94 💬
|
| 835 | Diagnostic Test: Multi modal MRI | - | - | - | - | [1] 6 6 💬
|
| 836 | Diagnostic Test: Multi-modal photoacoustic/ultrasonic (PA/US) imaging system | - | - | - | - | [1] 50 50 💬
|
| 837 | Diagnostic Test: Muscle Elastography | - | - | - | - | [1] 113 113 💬
|
| 838 | Diagnostic Test: Muscle ultrasound | - | - | - | - | [5] 3 3, 15, 111, 113, 256 💬
|
| 839 | Diagnostic Test: Myotonia (from Individualised Neuromuscular Quality of Life Questionnaire) | - | - | - | - | [1] 113 113 💬
|
| 840 | Diagnostic Test: Myotonia Behaviour scale | - | - | - | - | [1] 113 113 💬
|
| 841 | Diagnostic Test: Nasal brushing | - | - | - | - | [1] 299 299 💬
|
| 842 | Diagnostic Test: Neuro cognitive tests | - | - | - | - | [1] 235 235 💬
|
| 843 | Diagnostic Test: Neurological evaluation | - | - | - | - | [3] 2 2, 5, 127 💬
|
| 844 | Diagnostic Test: Neuropsychological assessment | - | - | - | - | [3] 5 5, 7, 127 💬
|
| 845 | Diagnostic Test: Neuropsychological evaluation | - | - | - | - | [3] 2 2, 5, 127 💬
|
| 846 | Diagnostic Test: neuropsychological test | - | - | - | - | [1] 7 7 💬
|
| 847 | Diagnostic Test: Neuropsycological assesment | - | - | - | - | [1] 6 6 💬
|
| 848 | Diagnostic Test: Neurosonology assessment | - | - | - | - | [1] 48 48 💬
|
| 849 | Diagnostic Test: Neutralizing Antibody to SPK-3006 capsid | - | - | - | - | [1] 256 256 💬
|
| 850 | Diagnostic Test: Neutrophil elastase and myeloperoxidase (NETs) markers | - | - | - | - | [1] 64 64 💬
|
| 851 | Diagnostic Test: NFL | - | - | - | - | [1] 64 64 💬
|
| 852 | Diagnostic Test: Nicotine and cotinine serum levels | [1] Nicotine Nicotine | [3] Nicotine
Nicotine
,
Nicotine bitartrate
,
Nicotine polacrilex
💬
| [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| [9] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | [1] 13 13 💬
|
| 853 | Diagnostic Test: Nociceptor flexor reflex | - | - | - | - | [1] 149 149 💬
|
| 854 | Diagnostic Test: NT3 blood draw | - | - | - | - | [2] 10 10, 14 💬
|
| 855 | Diagnostic Test: Obtaining Dry Blood Spots From Healthy Children Aged 8 Days - 7 Years | - | - | - | - | [10] 244 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
|
| 856 | Diagnostic Test: Obtaining Dry Blood Spots From Healthy Children Aged 8-18 Years | - | - | - | - | [10] 244 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
|
| 857 | Diagnostic Test: Obtaining Dry Blood Spots From Healthy Newborns (Aged 1-7 Days) | - | - | - | - | [10] 244 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
|
| 858 | Diagnostic Test: Obtaining Dry Blood Spots From High-risk childrens (Aged 8 - 18 years) | - | - | - | - | [10] 244 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
|
| 859 | Diagnostic Test: Obtaining Dry Blood Spots From High-risk childrens (Aged 8 Days- 7 years) | - | - | - | - | [10] 244 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
|
| 860 | Diagnostic Test: Obtaining Dry Blood Spots From High-risk Newborns (Aged 1-7 Days) | - | - | - | - | [10] 244 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
|
| 861 | Diagnostic Test: Ocular Coherence Tomography-Angiography (OCT-A) | - | - | - | - | [2] 90 90, 301 💬
|
| 862 | Diagnostic Test: Olfactory (smell) function testing | - | - | - | - | [1] 122 122 💬
|
| 863 | Diagnostic Test: Ommit routine blood test post operative day 1 | - | - | - | - | [1] 235 235 💬
|
| 864 | Diagnostic Test: Ophthalmological consultation | - | - | - | - | [1] 19 19 💬
|
| 865 | Diagnostic Test: Optical coherence tomography (OCT) | - | - | - | - | [1] 19 19 💬
|
| 866 | Diagnostic Test: Optical coherence tomography angiography | - | - | - | - | [1] 41 41 💬
|
| 867 | Diagnostic Test: Optional Muscle Biopsy | - | - | - | - | [1] 86 86 💬
|
| 868 | Diagnostic Test: Oral Glucose Tolerance Test | - | - | - | - | [6] 6 6, 13, 57, 65, 77, 299 💬
|
| 869 | Diagnostic Test: Oral microbiome | - | - | - | - | [1] 53 53 💬
|
| 870 | Diagnostic Test: P-MPA concentration | - | - | - | - | [1] 51 51 💬
|
| 871 | Diagnostic Test: P2X4 receptors in blood samples | - | - | - | - | [1] 2 2 💬
|
| 872 | Diagnostic Test: parasitological diagnostics (coproscopy) | - | - | - | - | [1] 97 97 💬
|
| 873 | Diagnostic Test: periodontitis-associated bacteria presence | - | - | - | - | [1] 46 46 💬
|
| 874 | Diagnostic Test: PET Imaging | - | - | - | - | [1] 85 85 💬
|
| 875 | Diagnostic Test: PET with [11C]Flumazenil | [1] Flumazenil Flumazenil | [1] Flumazenil
Flumazenil
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 13 13 💬
|
| 876 | Diagnostic Test: PET-CT Imaging with [89Zr]-bevacizumab | [1] Bevacizumab Bevacizumab | [1] Bevacizumab
Bevacizumab
💬
| [1] VEGFA VEGFA 💬
| [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [1] 86 86 💬
|
| 877 | Diagnostic Test: PET/CT scan | - | - | - | - | [1] 13 13 💬
|
| 878 | Diagnostic Test: Phosphorous Magnetic Resonance Spectroscopy | - | - | - | - | [1] 58 58 💬
|
| 879 | Diagnostic Test: Physical examination | - | - | - | - | [2] 49 49, 172 💬
|
| 880 | Diagnostic Test: Physical Examination and Questionnaires | - | - | - | - | [1] 98 98 💬
|
| 881 | Diagnostic Test: Plasma biomarkers | - | - | - | - | [1] 6 6 💬
|
| 882 | Diagnostic Test: Plasma RNA isolation, qPCR analysis of micro RNA | - | - | - | - | [1] 63 63 💬
|
| 883 | Diagnostic Test: Platelet function analyzer-100 | - | - | - | - | [2] 86 86, 88 💬
|
| 884 | Diagnostic Test: Polar H10 Heart Sensor | - | - | - | - | [1] 6 6 💬
|
| 885 | Diagnostic Test: Polysomnography | - | - | - | - | [1] 6 6 💬
|
| 886 | Diagnostic Test: Portable cardiac monitor CardioQvark | - | - | - | - | [2] 89 89, 299 💬
|
| 887 | Diagnostic Test: positron emission tomography | - | - | - | - | [1] 7 7 💬
|
| 888 | Diagnostic Test: Post treatment blood sample | - | - | - | - | [1] 96 96 💬
|
| 889 | Diagnostic Test: Post treatment intestinal biopsies | - | - | - | - | [1] 96 96 💬
|
| 890 | Diagnostic Test: Post treatment stool sample | - | - | - | - | [1] 96 96 💬
|
| 891 | Diagnostic Test: Postoperative laboratory blood tests at 24 hour | - | - | - | - | [1] 235 235 💬
|
| 892 | Diagnostic Test: Postoperative laboratory blood tests at 6 hour | - | - | - | - | [1] 235 235 💬
|
| 893 | Diagnostic Test: Postoperative laboratory drainage fluid tests at 24 hour | - | - | - | - | [1] 235 235 💬
|
| 894 | Diagnostic Test: pQCT | - | - | - | - | [1] 299 299 💬
|
| 895 | Diagnostic Test: Pregnancy Test | - | - | - | - | [1] 49 49 💬
|
| 896 | Diagnostic Test: Preoparative blood laboratory tests | - | - | - | - | [1] 235 235 💬
|
| 897 | Diagnostic Test: Pressure pain threshold | - | - | - | - | [4] 3 3, 15, 113, 256 💬
|
| 898 | Diagnostic Test: procalcitonin | [1] Procalcitonin Procalcitonin | - | - | - | [1] 299 299 💬
|
| 899 | Diagnostic Test: Procalcitonin-variants ELISA-Assay | [1] Procalcitonin Procalcitonin | - | - | - | [2] 43 43, 44 💬
|
| 900 | Diagnostic Test: Proteomic Analysis | - | - | - | - | [1] 64 64 💬
|
| 901 | Diagnostic Test: Proteomics | - | - | - | - | [1] 53 53 💬
|
| 902 | Diagnostic Test: prothrombin fragment 1+2 | [1] Prothrombin Prothrombin | - | - | - | [1] 35 35 💬
|
| 903 | Diagnostic Test: Psychosocial questionnaire: Hunger Vital Sign questionnaire | - | - | - | - | [1] 299 299 💬
|
| 904 | Diagnostic Test: PTX3 | - | - | - | - | [1] 64 64 💬
|
| 905 | Diagnostic Test: Pulmonary function test | - | - | - | - | [1] 51 51 💬
|
| 906 | Diagnostic Test: Pulmonary Function Testing (PFTs) | - | - | - | - | [1] 85 85 💬
|
| 907 | Diagnostic Test: Pulmonary microbiome probiotic | - | - | - | - | [1] 294 294 💬
|
| 908 | Diagnostic Test: Pulse Wave Velocity measurement | - | - | - | - | [1] 240 240 💬
|
| 909 | Diagnostic Test: Quality of Life Assessment - Baseline | - | - | - | - | [1] 18 18 💬
|
| 910 | Diagnostic Test: Quality of Life Assessment - Follow-up 12 months | - | - | - | - | [1] 18 18 💬
|
| 911 | Diagnostic Test: Quality of Life Assessment - Follow-up 24 months | - | - | - | - | [1] 18 18 💬
|
| 912 | Diagnostic Test: Quality of life questionnaire | - | - | - | - | [1] 210 210 💬
|
| 913 | Diagnostic Test: Quantitative microbiological test for HCV | - | - | - | - | [1] 63 63 💬
|
| 914 | Diagnostic Test: Quantitative muscle testing | - | - | - | - | [1] 113 113 💬
|
| 915 | Diagnostic Test: Questionnaires (Patient reported outcomes) | - | - | - | - | [1] 19 19 💬
|
| 916 | Diagnostic Test: Questionnaires on Quality of Life | - | - | - | - | [1] 235 235 💬
|
| 917 | Diagnostic Test: Quick Motor Function Test | - | - | - | - | [4] 3 3, 15, 113, 256 💬
|
| 918 | Diagnostic Test: R-PAct | - | - | - | - | [1] 113 113 💬
|
| 919 | Diagnostic Test: R-PAct (Questionnaire) | - | - | - | - | [3] 3 3, 15, 256 💬
|
| 920 | Diagnostic Test: r-r interval variability with deep breathing | - | - | - | - | [1] 266 266 💬
|
| 921 | Diagnostic Test: r-r interval variability with normal breathing | - | - | - | - | [1] 266 266 💬
|
| 922 | Diagnostic Test: Radiological tests | - | - | - | - | [1] 77 77 💬
|
| 923 | Diagnostic Test: Recording of vital signs | - | - | - | - | [1] 172 172 💬
|
| 924 | Diagnostic Test: Rectosigmoidoscopy | - | - | - | - | [1] 97 97 💬
|
| 925 | Diagnostic Test: Respiratory Assessments | - | - | - | - | [1] 111 111 💬
|
| 926 | Diagnostic Test: Rest of ANA profile | - | - | - | - | [1] 49 49 💬
|
| 927 | Diagnostic Test: Retrospective evaluation of endoscopy prior to study drug | - | - | - | - | [1] 98 98 💬
|
| 928 | Diagnostic Test: Right Heart Catheterization (RHC) while exercising | - | - | - | - | [1] 86 86 💬
|
| 929 | Diagnostic Test: RNA sequencing | - | - | - | - | [1] 53 53 💬
|
| 930 | Diagnostic Test: Rotational thromboelastometry | - | - | - | - | [2] 86 86, 88 💬
|
| 931 | Diagnostic Test: Rotterdam Handicap Scale (RHS) (Questionnaire) | - | - | - | - | [3] 3 3, 15, 256 💬
|
| 932 | Diagnostic Test: Routine blood chemistry analysis and genetic analysis | - | - | - | - | [1] 2 2 💬
|
| 933 | Diagnostic Test: Routine MRI scan | - | - | - | - | [1] 75 75 💬
|
| 934 | Diagnostic Test: Saliva | - | - | - | - | [1] 96 96 💬
|
| 935 | Diagnostic Test: Saliva sample | - | - | - | - | [1] 298 298 💬
|
| 936 | Diagnostic Test: Saliva swab | - | - | - | - | [1] 75 75 💬
|
| 937 | Diagnostic Test: Scale for Assessment and Rating of Ataxia | - | - | - | - | [1] 113 113 💬
|
| 938 | Diagnostic Test: sCD40L | - | - | - | - | [1] 64 64 💬
|
| 939 | Diagnostic Test: Schirmer's test | - | - | - | - | [1] 53 53 💬
|
| 940 | Diagnostic Test: Search for thyroid disorders | - | - | - | - | [1] 63 63 💬
|
| 941 | Diagnostic Test: Second alkaline phosphatase measurement | [1] Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [1] 172 172 💬
|
| 942 | Diagnostic Test: Serological assay for blood born viral hepatitis | - | - | - | - | [1] 63 63 💬
|
| 943 | Diagnostic Test: Serum 25(OH)D (Vitamin D3), C- reactive protein, Erthrocyte sedimentation rate | - | - | - | - | [1] 97 97 💬
|
| 944 | Diagnostic Test: Serum acetylcholine receptor antibody, erythrocyte deposition rate, hypersensitive C protein, neostigmine test,thymus CT, low frequency repeated nerve stimulation | [2] Acetylcholine Acetylcholine, Neostigmine | [4] Neostigmine bromide
Neostigmine bromide
,
Neostigmine methylsulfate
,
Acetylcholine chloride
,
Neostigmine
💬
| [22] ACHE ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| [18] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Glycerophospholipid metabolism, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, Virion - Ebolavirus, Lyssavirus and Morbillivirus, cAMP signaling pathway 💬 | [1] 11 11 💬
|
| 945 | Diagnostic Test: serum albumin | - | - | - | - | [1] 107 107 💬
|
| 946 | Diagnostic Test: serum albumin level | - | - | - | - | [1] 97 97 💬
|
| 947 | Diagnostic Test: Serum and urine biomarkers | - | - | - | - | [1] 19 19 💬
|
| 948 | Diagnostic Test: Serum biomarkers | - | - | - | - | [1] 98 98 💬
|
| 949 | Diagnostic Test: serum calcium level | [1] Calcium Calcium | - | - | - | [1] 97 97 💬
|
| 950 | Diagnostic Test: serum ceramides level in blood | - | - | - | - | [1] 49 49 💬
|
| 951 | Diagnostic Test: serum creatinine | [1] Creatinine Creatinine | [1] Creatinine
Creatinine
💬
| - | - | [1] 97 97 💬
|
| 952 | Diagnostic Test: Serum creatinine and Alb/create ratio | [1] Creatinine Creatinine | [1] Creatinine
Creatinine
💬
| - | - | [1] 49 49 💬
|
| 953 | Diagnostic Test: Serum IL10 By ELISA | - | - | - | - | [1] 63 63 💬
|
| 954 | Diagnostic Test: serum interleukin 10 level | - | - | - | - | [1] 63 63 💬
|
| 955 | Diagnostic Test: serum lactate | - | - | - | - | [1] 97 97 💬
|
| 956 | Diagnostic Test: serum leucine-rich alpha-2 glycoprotein (LRG) levels | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [2] 96 96, 97 💬
|
| 957 | Diagnostic Test: Serum Metal ion levels determined to monitor changes in chromium and cobalt levels | [2] Chromium Chromium, Cobalt | - | - | - | [1] 46 46 💬
|
| 958 | Diagnostic Test: serum phosphurus level | - | - | - | - | [1] 97 97 💬
|
| 959 | Diagnostic Test: serum potassium level | [1] Potassium Potassium | [1] Potassium
Potassium
💬
| - | - | [1] 97 97 💬
|
| 960 | Diagnostic Test: serum protein ,kidney function ,liver function.,serum cholesterol | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [1] 222 222 💬
|
| 961 | Diagnostic Test: serum total 25 hydroxycholecalciferol 25(OH) vitamin D | [1] Vitamin D Vitamin D | - | - | - | [1] 97 97 💬
|
| 962 | Diagnostic Test: seum alanine aminotransferase | [1] Alanine Alanine | [1] Alanine
Alanine
💬
| - | - | [1] 97 97 💬
|
| 963 | Diagnostic Test: SF-36 | - | - | - | - | [1] 172 172 💬
|
| 964 | Diagnostic Test: Sham Comparator: Controls | - | - | - | - | [1] 6 6 💬
|
| 965 | Diagnostic Test: Short Performance Physical Battery | - | - | - | - | [1] 86 86 💬
|
| 966 | Diagnostic Test: Short physical performance battery (SPPB) | - | - | - | - | [1] 299 299 💬
|
| 967 | Diagnostic Test: Short physical performance battery (SPPB) score | - | - | - | - | [1] 172 172 💬
|
| 968 | Diagnostic Test: simultaneous combined 18F-FDG PET and cardiac MRI imaging | - | - | - | - | [1] 84 84 💬
|
| 969 | Diagnostic Test: Sit-to-Stand Test | - | - | - | - | [1] 299 299 💬
|
| 970 | Diagnostic Test: Six minute walk test | - | - | - | - | [1] 86 86 💬
|
| 971 | Diagnostic Test: Six minute walking test | - | - | - | - | [1] 113 113 💬
|
| 972 | Diagnostic Test: Six-minute walk Test | - | - | - | - | [1] 299 299 💬
|
| 973 | Diagnostic Test: Six-minute walk test (6MWT) | - | - | - | - | [3] 3 3, 15, 256 💬
|
| 974 | Diagnostic Test: Skin biopsies | - | - | - | - | [1] 51 51 💬
|
| 975 | Diagnostic Test: Skin biopsy | - | - | - | - | [1] 10 10 💬
|
| 976 | Diagnostic Test: SLE activity evaluation | - | - | - | - | [1] 49 49 💬
|
| 977 | Diagnostic Test: SLE biomarker profiling | - | - | - | - | [1] 49 49 💬
|
| 978 | Diagnostic Test: slow vital capacity | - | - | - | - | [1] 2 2 💬
|
| 979 | Diagnostic Test: Smell test | - | - | - | - | [1] 6 6 💬
|
| 980 | Diagnostic Test: SNP -3279 A/C of FOXP3 | - | - | - | - | [1] 63 63 💬
|
| 981 | Diagnostic Test: SNP-924 A/G Of FOXP3 | - | - | - | - | [1] 63 63 💬
|
| 982 | Diagnostic Test: soluble C5b-9 | - | - | - | - | [1] 64 64 💬
|
| 983 | Diagnostic Test: sP-selectin | - | - | - | - | [1] 64 64 💬
|
| 984 | Diagnostic Test: SPECT/CT Imaging | - | - | - | - | [1] 98 98 💬
|
| 985 | Diagnostic Test: Spin-lattice relaxation (T1) | - | - | - | - | [2] 96 96, 97 💬
|
| 986 | Diagnostic Test: Spirometry | - | - | - | - | [4] 84 84, 228, 299, 340 💬
|
| 987 | Diagnostic Test: Static retinal vessel analysis (SVA) | - | - | - | - | [1] 19 19 💬
|
| 988 | Diagnostic Test: Stool | - | - | - | - | [2] 96 96, 97 💬
|
| 989 | Diagnostic Test: stool biomarkers | - | - | - | - | [1] 96 96 💬
|
| 990 | Diagnostic Test: Stool Routine Test at 12-week | - | - | - | - | [1] 97 97 💬
|
| 991 | Diagnostic Test: Stool Routine Test at 4-week | - | - | - | - | [1] 97 97 💬
|
| 992 | Diagnostic Test: Stool Routine Test at 8-week | - | - | - | - | [1] 97 97 💬
|
| 993 | Diagnostic Test: Stool samplong | - | - | - | - | [1] 97 97 💬
|
| 994 | Diagnostic Test: Stroop test | - | - | - | - | [1] 13 13 💬
|
| 995 | Diagnostic Test: Subcutaneous administration of recombinant human IGF-1 | - | - | - | - | [1] 77 77 💬
|
| 996 | Diagnostic Test: sweat chloride test | - | - | - | - | [1] 299 299 💬
|
| 997 | Diagnostic Test: sympathetic skin response | - | - | - | - | [1] 266 266 💬
|
| 998 | Diagnostic Test: Symptom and clinical findings checklist for hypophosphatasia | - | - | - | - | [1] 172 172 💬
|
| 999 | Diagnostic Test: Take blood samples | - | - | - | - | [1] 56 56 💬
|
| 1000 | Diagnostic Test: Technetium99m - Sulfur Colloid (Tc99m-SC) | - | - | - | - | [1] 340 340 💬
|
| 1001 | Diagnostic Test: Technochrom C1-INH Kit | - | - | - | - | [1] 65 65 💬
|
| 1002 | Diagnostic Test: Testing of autonomous nervous system function | - | - | - | - | [1] 13 13 💬
|
| 1003 | Diagnostic Test: The Juvenile Disease Activity Score (JADAS) | - | - | - | - | [1] 107 107 💬
|
| 1004 | Diagnostic Test: Thermography | - | - | - | - | [1] 6 6 💬
|
| 1005 | Diagnostic Test: Thoracic CT scan | - | - | - | - | [1] 229 229 💬
|
| 1006 | Diagnostic Test: Tilt table test | - | - | - | - | [1] 6 6 💬
|
| 1007 | Diagnostic Test: Total body magnetic resonance imaging | - | - | - | - | [1] 77 77 💬
|
| 1008 | Diagnostic Test: Traditional Chinese Medicine pattern | - | - | - | - | [1] 53 53 💬
|
| 1009 | Diagnostic Test: Traditional Chinese Medicine pulse diagnosis | - | - | - | - | [1] 53 53 💬
|
| 1010 | Diagnostic Test: Traditional Chinese Medicine tongue diagnosis | - | - | - | - | [1] 53 53 💬
|
| 1011 | Diagnostic Test: transient elastography (FibroScan) | - | - | - | - | [1] 65 65 💬
|
| 1012 | Diagnostic Test: Transorbital Ultrasound | - | - | - | - | [1] 41 41 💬
|
| 1013 | Diagnostic Test: Triptorelin acetate and Gonadorelin acetate | [3] Acetate Acetate, Gonadorelin, Triptorelin | [6] Gonadorelin hydrochloride
Gonadorelin hydrochloride
,
Gonadorelin acetate
,
Triptorelin
,
Triptorelin pamoate
,
Gonadorelin
,
Triptorelin acetate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 💬
|
| 1014 | Diagnostic Test: Ultrasonographic assessment of Cervical Multifidus and Longus Colli Muscle Thickness, Postural Balance and Limit of Stability using the balance platform,Cervical Flexion and Extension Strength | - | - | - | - | [1] 271 271 💬
|
| 1015 | Diagnostic Test: ultrasonography | - | - | - | - | [1] 2 2 💬
|
| 1016 | Diagnostic Test: Ultrasound | - | - | - | - | [2] 46 46, 97 💬
|
| 1017 | Diagnostic Test: Ultrasound of pancreas | - | - | - | - | [1] 84 84 💬
|
| 1018 | Diagnostic Test: Ultrasound Sub-study of assessment of appendage muscles using ultrasound | - | - | - | - | [1] 299 299 💬
|
| 1019 | Diagnostic Test: Upper member arterial Doppler echography with analysis of FMD | - | - | - | - | [1] 58 58 💬
|
| 1020 | Diagnostic Test: Urea cycle flux study | [1] Urea Urea | [2] Urea
Urea
,
Urea C13
💬
| - | - | [1] 251 251 💬
|
| 1021 | Diagnostic Test: Urinalysis | - | - | - | - | [1] 49 49 💬
|
| 1022 | Diagnostic Test: urine and blood test | - | - | - | - | [1] 171 171 💬
|
| 1023 | Diagnostic Test: urine sample | - | - | - | - | [2] 72 72, 298 💬
|
| 1024 | Diagnostic Test: Urine Testing | - | - | - | - | [1] 254 254 💬
|
| 1025 | Diagnostic Test: Urodynamic Testing | - | - | - | - | [1] 118 118 💬
|
| 1026 | Diagnostic Test: Valsalva ratio | - | - | - | - | [1] 266 266 💬
|
| 1027 | Diagnostic Test: Vascular ultrasound | - | - | - | - | [1] 41 41 💬
|
| 1028 | Diagnostic Test: Vasculopathy assessment | - | - | - | - | [1] 51 51 💬
|
| 1029 | Diagnostic Test: VCAM | - | - | - | - | [1] 64 64 💬
|
| 1030 | Diagnostic Test: VEGF-A | - | - | - | - | [1] 64 64 💬
|
| 1031 | Diagnostic Test: Venous blood sample | - | - | - | - | [1] 84 84 💬
|
| 1032 | Diagnostic Test: Vestibular/balance assessment | - | - | - | - | [1] 122 122 💬
|
| 1033 | Diagnostic Test: Virtual reality | - | - | - | - | [1] 6 6 💬
|
| 1034 | Diagnostic Test: Vital signs | - | - | - | - | [3] 3 3, 15, 256 💬
|
| 1035 | Diagnostic Test: Vitamin D Measurement | [1] Vitamin D Vitamin D | - | - | - | [1] 98 98 💬
|
| 1036 | Diagnostic Test: VOC probiotic | - | - | - | - | [1] 294 294 💬
|
| 1037 | Diagnostic Test: Von Willebrand factor (VWF) antigen | - | - | - | - | [1] 64 64 💬
|
| 1038 | Diagnostic Test: VWF multimers | - | - | - | - | [1] 64 64 💬
|
| 1039 | Diagnostic Test: VWF-propeptide | - | - | - | - | [1] 64 64 💬
|
| 1040 | Diagnostic Test: VWF:RCo | - | - | - | - | [1] 64 64 💬
|
| 1041 | Diagnostic Test: Whole body Phe oxidation testing | - | - | - | - | [1] 240 240 💬
|
| 1042 | Diagnostic Test: Xenon MRI | [1] Xenon Xenon | [2] Xenon
Xenon
,
Xenon Xe 133
💬
| - | - | [1] 299 299 💬
|
| 1043 | Diagnostic Test: Zirconium Zr 89 labelled rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 41 41 💬
|
| 1044 | Diagnostic Test: • Complete blood count , MPV | - | - | - | - | [1] 48 48 💬
|
| 1045 | Diammonium glycyrrhizinate enteric-coated capsule | - | - | - | - | [1] 63 63 💬
|
| 1046 | DIAMOX | - | - | - | - | [1] 230 230 💬
|
| 1047 | Diazepam | [1] Diazepam Diazepam | [1] Diazepam
Diazepam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [3] 46 46, 155, 298 💬
|
| 1048 | Diazepam, melatonin | [2] Diazepam Diazepam, Melatonin | [2] Diazepam
Diazepam
,
Melatonin
💬
| [18] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, MTNR1A, MTNR1B 💬
| [10] Cadherin signaling Cadherin signaling, Circadian entrainment, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 46 46 💬
|
| 1049 | Diazoxide | [1] Diazoxide Diazoxide | [2] Diazoxide
Diazoxide
,
Diazoxide choline
💬
| [2] ABCC8 ABCC8, KCNJ11 💬
| [4] ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [2] 13 13, 193 💬
|
| 1050 | DIAZOXIDE CHOLINE | [2] Choline Choline, Diazoxide | [3] Diazoxide
Diazoxide
,
Choline
,
Diazoxide choline
💬
| [2] ABCC8 ABCC8, KCNJ11 💬
| [4] ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [1] 193 193 💬
|
| 1051 | Diazoxide choline controlled-release tablet | [2] Choline Choline, Diazoxide | [3] Diazoxide
Diazoxide
,
Choline
,
Diazoxide choline
💬
| [2] ABCC8 ABCC8, KCNJ11 💬
| [4] ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [1] 193 193 💬
|
| 1052 | DIBASE | - | - | - | - | [1] 13 13 💬
|
| 1053 | DIBASE*IM OS 2F 1ML 300000UI/M | - | - | - | - | [1] 46 46 💬
|
| 1054 | Dichloroacetate | - | - | - | - | [1] 21 21 💬
|
| 1055 | Dichloroacetate Sodium | - | - | - | - | [1] 86 86 💬
|
| 1056 | Dichlorphenamide | - | - | - | - | [2] 114 114, 115 💬
|
| 1057 | Dichlorphenamide (double-blind) | - | - | - | - | [1] 115 115 💬
|
| 1058 | Dichlorphenamide (open-label) | - | - | - | - | [1] 115 115 💬
|
| 1059 | Diclofenac | [1] Diclofenac Diclofenac | [5] Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [5] 13 13, 34, 46, 78, 271 💬
|
| 1060 | Diclofenac + Omeprazole | [2] Diclofenac Diclofenac, Omeprazole | [8] Omeprazole
Omeprazole
,
Diclofenac potassium
,
Diclofenac sodium
,
Omeprazole sodium
,
Omeprazole magnesium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| [4] ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬
| [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Efferocytosis, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 1061 | Diclofenac 50 milligrams | [1] Diclofenac Diclofenac | [5] Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 1062 | Diclofenac Sodium | [1] Diclofenac Diclofenac | [5] Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 34 34, 46 💬
|
| 1063 | Diclofenac sodium topical gel | [1] Diclofenac Diclofenac | [5] Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 💬
|
| 1064 | Diclofenac SR | [1] Diclofenac Diclofenac | [5] Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 1065 | Diclophenac | - | - | - | - | [1] 271 271 💬
|
| 1066 | DICLOXACILLIN | [1] Dicloxacillin Dicloxacillin | [2] Dicloxacillin sodium
Dicloxacillin sodium
,
Dicloxacillin
💬
| - | - | [1] 299 299 💬
|
| 1067 | Dicynone | - | - | - | - | [1] 227 227 💬
|
| 1068 | Didanosine | [1] Didanosine Didanosine | [1] Didanosine
Didanosine
💬
| - | - | [2] 25 25, 265 💬
|
| 1069 | Diet | - | - | - | - | [5] 86 86, 95, 97, 240, 299 💬
|
| 1070 | Diet 1 | - | - | - | - | [2] 96 96, 97 💬
|
| 1071 | Diet 2 | - | - | - | - | [2] 96 96, 97 💬
|
| 1072 | Diet A group | - | - | - | - | [1] 85 85 💬
|
| 1073 | Diet B group | - | - | - | - | [1] 85 85 💬
|
| 1074 | Diet C group | - | - | - | - | [1] 85 85 💬
|
| 1075 | Dietanolamina de treprostinilo | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 1076 | Dietary assignment | - | - | - | - | [1] 95 95 💬
|
| 1077 | Dietary Fiber Mixture | - | - | - | - | [1] 97 97 💬
|
| 1078 | Dietary Fiber Supplementation | - | - | - | - | [1] 46 46 💬
|
| 1079 | Dietary methionine tracer and protein intake | [1] Methionine Methionine | [1] Methionine
Methionine
💬
| - | - | [1] 337 337 💬
|
| 1080 | Dietary nitrate | [1] Nitrate Nitrate | [1] Nitric acid
Nitric acid
💬
| - | - | [1] 57 57 💬
|
| 1081 | Dietary Supplement for PKU patients | - | - | - | - | [1] 240 240 💬
|
| 1082 | Dietary supplement omega3 fatty acids aand vitamins | - | - | - | - | [1] 46 46 💬
|
| 1083 | Dietary Supplement: vitamin A | [1] Vitamin A Vitamin A | [2] Vitamin A oil
Vitamin A oil
,
Vitamin A
💬
| [2] RARA RARA, RARB 💬
| [8] Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [1] 13 13 💬
|
| 1084 | Dietary Supplements: Vitamins, Minerals, Herbs, etc. | - | - | - | - | [2] 2 2, 4 💬
|
| 1085 | Dietary therapy | - | - | - | - | [2] 96 96, 97 💬
|
| 1086 | Diethanolamine | [1] Diethanolamine Diethanolamine | [1] Diethanolamine
Diethanolamine
💬
| - | - | [2] 51 51, 86 💬
|
| 1087 | Diethyl-[6-(4-hydroxycarbamoyl- phenyl carbamoyloxymethyl)-naphthalen-2-yl methyl]-ammonium chloride | [1] Ammonium chloride Ammonium chloride | [1] Ammonium chloride
Ammonium chloride
💬
| - | - | [1] 107 107 💬
|
| 1088 | Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon | [1] Ammonium chloride Ammonium chloride | [1] Ammonium chloride
Ammonium chloride
💬
| - | - | [1] 96 96 💬
|
| 1089 | Dietician designed diet | - | - | - | - | [1] 96 96 💬
|
| 1090 | Difenidramina | - | - | - | - | [2] 11 11, 63 💬
|
| 1091 | DIFENIDRAMINA CLORIDRATO | - | - | - | - | [3] 11 11, 19, 63 💬
|
| 1092 | Different diets | - | - | - | - | [1] 6 6 💬
|
| 1093 | Different HAART regimens | - | - | - | - | [1] 265 265 💬
|
| 1094 | Dificlir | - | - | - | - | [1] 97 97 💬
|
| 1095 | DIFICLIR - 200 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE -BLISTER (ALU/ALU) 2X10 COMPRESSE | - | - | - | - | [1] 97 97 💬
|
| 1096 | DIFICLIR 200 mg compresse rivestite con film | - | - | - | - | [1] 97 97 💬
|
| 1097 | DIFICLIR 200 mg film-coated tablets | - | - | - | - | [1] 97 97 💬
|
| 1098 | Diflucan | [1] Fluconazole Fluconazole | [1] Fluconazole
Fluconazole
💬
| - | - | [1] 96 96 💬
|
| 1099 | Diflunisal | [1] Diflunisal Diflunisal | [1] Diflunisal
Diflunisal
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 28 28 💬
|
| 1100 | Diflunisal (dolobid) | [1] Diflunisal Diflunisal | [1] Diflunisal
Diflunisal
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 28 28 💬
|
| 1101 | DIGIPARK MONITOR | - | - | - | - | [1] 6 6 💬
|
| 1102 | Digital Biomarkers | - | - | - | - | [1] 111 111 💬
|
| 1103 | Digital recording of speech and swallow sounds using the Beiwe Digital Health App on a personal smartphone | - | - | - | - | [1] 2 2 💬
|
| 1104 | Digitoxin | [1] Digitoxin Digitoxin | [1] Digitoxin
Digitoxin
💬
| [4] ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬
| [19] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬
|
| 1105 | DIGNA P144 CREAM | - | - | - | - | [1] 51 51 💬
|
| 1106 | Digoxin | [1] Digoxin Digoxin | [1] Digoxin
Digoxin
💬
| [4] ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬
| [19] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 2 2, 8, 46, 57, 65, 67, 210 💬
|
| 1107 | Digoxin 0.25 mg | [1] Digoxin Digoxin | [1] Digoxin
Digoxin
💬
| [4] ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬
| [19] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 💬
|
| 1108 | Digoxin+furosemide+captopril | [3] Captopril Captopril, Digoxin, Furosemide | [3] Captopril
Captopril
,
Digoxin
,
Furosemide
💬
| [6] ACE ACE, ATP1A1, ATP1A2, ATP1A3, ATP1A4, SLC12A2 💬
| [26] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chagas disease, Coronavirus disease, Cytoskeleton in muscle cells, Diabetic cardiomyopathy, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Hypertrophic cardiomyopathy, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Renin secretion, Renin-angiotensin system, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 57 57 💬
|
| 1109 | Dihydroartemisinin tablet | - | - | - | - | [1] 49 49 💬
|
| 1110 | Dihydroergot mesylate | - | - | - | - | [1] 6 6 💬
|
| 1111 | Dihydroergotine mesylate sustained-release tablets | - | - | - | - | [1] 6 6 💬
|
| 1112 | Dihydroergotoxine | [1] Dihydroergotoxine Dihydroergotoxine | [1] Dihydroergotoxine
Dihydroergotoxine
💬
| - | - | [1] 6 6 💬
|
| 1113 | DILATREND | - | - | - | - | [1] 113 113 💬
|
| 1114 | Diltiazem | [1] Diltiazem Diltiazem | [3] Diltiazem hydrochloride
Diltiazem hydrochloride
,
Diltiazem malate
,
Diltiazem
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 51 51, 58, 86, 88 💬
|
| 1115 | Diltiazem Gel 2% | [1] Diltiazem Diltiazem | [3] Diltiazem hydrochloride
Diltiazem hydrochloride
,
Diltiazem malate
,
Diltiazem
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 1116 | Diltiazem Hydrochloride | [1] Diltiazem Diltiazem | [3] Diltiazem hydrochloride
Diltiazem hydrochloride
,
Diltiazem malate
,
Diltiazem
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 1117 | Dimebon | - | - | - | - | [1] 8 8 💬
|
| 1118 | Dimebon (latrepirdine) | [1] Latrepirdine Latrepirdine | [2] Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| [6] ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [23] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 8 8 💬
|
| 1119 | Dimebon + Dextromethorphan | [1] Dextromethorphan Dextromethorphan | [3] Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Dextromethorphan polistirex
💬
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 8 8 💬
|
| 1120 | Dimebon + Ketoconazole | [1] Ketoconazole Ketoconazole | [1] Ketoconazole
Ketoconazole
💬
| - | - | [1] 8 8 💬
|
| 1121 | Dimebon + Omeprazole | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 8 8 💬
|
| 1122 | Dimebon alone | - | - | - | - | [1] 8 8 💬
|
| 1123 | Dimebon Dihydrochloride | - | - | - | - | [1] 8 8 💬
|
| 1124 | Dimebon IR | - | - | - | - | [1] 8 8 💬
|
| 1125 | Dimebon IR Tablet | - | - | - | - | [1] 8 8 💬
|
| 1126 | Dimebon MR1 | - | - | - | - | [1] 8 8 💬
|
| 1127 | Dimebon MR2 | - | - | - | - | [1] 8 8 💬
|
| 1128 | Dimebon MR3 | - | - | - | - | [1] 8 8 💬
|
| 1129 | Dimebon MR4 | - | - | - | - | [1] 8 8 💬
|
| 1130 | Dimebon Transdermal | - | - | - | - | [1] 8 8 💬
|
| 1131 | Dimebutic acid | - | - | - | - | [2] 245 245, 246 💬
|
| 1132 | DIMETHYL FUMARATE | [1] Dimethyl fumarate Dimethyl fumarate | [1] Dimethyl fumarate
Dimethyl fumarate
💬
| [1] KEAP1 KEAP1 💬
| [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [5] 13 13, 20, 51, 86, 296 💬
|
| 1133 | Dimethyl Fumarate (DMF) | [1] Dimethyl fumarate Dimethyl fumarate | [1] Dimethyl fumarate
Dimethyl fumarate
💬
| [1] KEAP1 KEAP1 💬
| [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [3] 13 13, 51, 86 💬
|
| 1134 | Dimethyl fumarate 240 mg | [1] Dimethyl fumarate Dimethyl fumarate | [1] Dimethyl fumarate
Dimethyl fumarate
💬
| [1] KEAP1 KEAP1 💬
| [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [1] 13 13 💬
|
| 1135 | Dimethyl Fumarate 240 MG [Tecfidera] | [1] Dimethyl fumarate Dimethyl fumarate | [1] Dimethyl fumarate
Dimethyl fumarate
💬
| [1] KEAP1 KEAP1 💬
| [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [1] 13 13 💬
|
| 1136 | Dimethyl fumarate [DMF] | [1] Dimethyl fumarate Dimethyl fumarate | [1] Dimethyl fumarate
Dimethyl fumarate
💬
| [1] KEAP1 KEAP1 💬
| [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [1] 13 13 💬
|
| 1137 | Dimethyl Fumarate Enteric-coated Capsules | [1] Dimethyl fumarate Dimethyl fumarate | [1] Dimethyl fumarate
Dimethyl fumarate
💬
| [1] KEAP1 KEAP1 💬
| [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [1] 13 13 💬
|
| 1138 | Dimethyl sulfoxide | [1] Dimethyl sulfoxide Dimethyl sulfoxide | [1] Dimethyl sulfoxide
Dimethyl sulfoxide
💬
| - | - | [1] 226 226 💬
|
| 1139 | Dimethyl sulfoxide (DMSO) | [1] Dimethyl sulfoxide Dimethyl sulfoxide | [1] Dimethyl sulfoxide
Dimethyl sulfoxide
💬
| - | - | [1] 226 226 💬
|
| 1140 | Dimethylfumarat | - | - | - | - | [1] 49 49 💬
|
| 1141 | DIMETIL-FUMARATO | - | - | - | - | [1] 13 13 💬
|
| 1142 | Dimetilfumarato | - | - | - | - | [1] 13 13 💬
|
| 1143 | Dimeythl Fumarate | - | - | - | - | [1] 46 46 💬
|
| 1144 | DIMS0150 | - | - | - | - | [1] 97 97 💬
|
| 1145 | Diode laser for photobiomodulation | - | - | - | - | [1] 35 35 💬
|
| 1146 | Diosmin | [1] Diosmin Diosmin | [1] Diosmin
Diosmin
💬
| - | - | [4] 46 46, 51, 97, 265 💬
|
| 1147 | Diosmin and Hesperidin Combination | [2] Diosmin Diosmin, Hesperidin | [2] Hesperidin
Hesperidin
,
Diosmin
💬
| - | - | [1] 46 46 💬
|
| 1148 | Diosminex, 500 mg, tabletki powlekane | - | - | - | - | [1] 265 265 💬
|
| 1149 | Diovan | - | - | - | - | [2] 58 58, 208 💬
|
| 1150 | Diovan (Valsartan/VAL489) | [1] Valsartan Valsartan | [1] Valsartan
Valsartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1151 | Diovan 160 mg | - | - | - | - | [1] 58 58 💬
|
| 1152 | Diovan 40 mg | - | - | - | - | [1] 58 58 💬
|
| 1153 | Diovan 80 mg | - | - | - | - | [1] 58 58 💬
|
| 1154 | Diphenhydramine | [1] Diphenhydramine Diphenhydramine | [4] Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [12] 11 11, 13, 19, 49, 51, 63, 70, 86, 96, 222, 256, 300 💬
|
| 1155 | Diphenhydramine hydrochloride | [1] Diphenhydramine Diphenhydramine | [4] Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [3] 11 11, 49, 222 💬
|
| 1156 | Diphenhydramine IV | [1] Diphenhydramine Diphenhydramine | [4] Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 1157 | Diphenydramine | - | - | - | - | [1] 13 13 💬
|
| 1158 | Diphtheria booster vaccination | - | - | - | - | [1] 97 97 💬
|
| 1159 | DIPHTHERIA TOXOID | - | - | - | - | [1] 46 46 💬
|
| 1160 | Dipivefrin | [1] Dipivefrin Dipivefrin | [2] Dipivefrin hydrochloride
Dipivefrin hydrochloride
,
Dipivefrin
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 1161 | Diponecaftor | - | - | - | - | [1] 299 299 💬
|
| 1162 | Dipotassium Salt | - | - | - | - | [1] 46 46 💬
|
| 1163 | Dipraglurant | [1] Dipraglurant Dipraglurant | - | - | - | [1] 6 6 💬
|
| 1164 | Diprofos Depot | - | - | - | - | [1] 46 46 💬
|
| 1165 | Dipyridamole | [1] Dipyridamole Dipyridamole | [1] Dipyridamole
Dipyridamole
💬
| [2] PDE4A PDE4A, PDE5A 💬
| [5] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 46 46, 49, 51, 66, 96, 222, 224 💬
|
| 1166 | Dipyridamole and Amoxapine | [2] Amoxapine Amoxapine, Dipyridamole | [2] Amoxapine
Amoxapine
,
Dipyridamole
💬
| [4] PDE4A PDE4A, PDE5A, SLC6A2, SLC6A4 💬
| [8] Morphine addiction Morphine addiction, Neuroactive ligand signaling, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 💬
|
| 1167 | Dipyridamole Tab 25 MG | [1] Dipyridamole Dipyridamole | [1] Dipyridamole
Dipyridamole
💬
| [2] PDE4A PDE4A, PDE5A 💬
| [5] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 224 224 💬
|
| 1168 | Diquafosol | [1] Diquafosol Diquafosol | [1] Diquafosol tetrasodium
Diquafosol tetrasodium
💬
| [1] P2RY2 P2RY2 💬
| [4] Efferocytosis Efferocytosis, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 53 53 💬
|
| 1169 | Direct intravenous injection of ivlv-X1 lentiviral vector | - | - | - | - | [1] 65 65 💬
|
| 1170 | Direct Puncture Repair / Ethanol | [1] Ethanol Ethanol | [2] Alcohol
Alcohol
,
Ethanol
💬
| - | - | [1] 279 279 💬
|
| 1171 | Direct Puncture Repair / Polidocanol | [1] Polidocanol Polidocanol | [2] Laureth 4
Laureth 4
,
Polidocanol
💬
| - | - | [1] 279 279 💬
|
| 1172 | Direct surgery for acromegaly | - | - | - | - | [1] 77 77 💬
|
| 1173 | Diroximel Fumarate | [1] Diroximel fumarate Diroximel fumarate | [1] Diroximel fumarate
Diroximel fumarate
💬
| - | - | [1] 13 13 💬
|
| 1174 | Diroximel Fumarate (DRF) | [1] Diroximel fumarate Diroximel fumarate | [1] Diroximel fumarate
Diroximel fumarate
💬
| - | - | [1] 13 13 💬
|
| 1175 | Dirucotide | [1] Dirucotide Dirucotide | [1] Dirucotide
Dirucotide
💬
| - | - | [1] 13 13 💬
|
| 1176 | Dirucotide acetate | [2] Acetate Acetate, Dirucotide | [1] Dirucotide
Dirucotide
💬
| - | - | [1] 13 13 💬
|
| 1177 | DISC-0974 | - | - | - | - | [1] 97 97 💬
|
| 1178 | DISC-1459 | - | - | - | - | [1] 254 254 💬
|
| 1179 | Discontinuation of disease modifying therapy | - | - | - | - | [1] 13 13 💬
|
| 1180 | Discontinuation of eltrombopag | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 1181 | Discontinuation of Pancreatic Enzyme Replacement Therapy | - | - | - | - | [1] 299 299 💬
|
| 1182 | Discontinuation of respiratory co-therapy (azithromycin, RhDNase, or inhaled antibiotics) | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 299 299 💬
|
| 1183 | Discontinuation of riociguat | [1] Riociguat Riociguat | [1] Riociguat
Riociguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 88 88 💬
|
| 1184 | Discontinuation of thiopurines. | - | - | - | - | [1] 97 97 💬
|
| 1185 | Discontinue Tocilizumab | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬
|
| 1186 | Disease modified antirheumatic drugs or biological agents | - | - | - | - | [1] 46 46 💬
|
| 1187 | Disease Modifying therapy | - | - | - | - | [1] 13 13 💬
|
| 1188 | Disease modifying treatment (DMT) | - | - | - | - | [1] 13 13 💬
|
| 1189 | Disease modifying treatments | - | - | - | - | [1] 3 3 💬
|
| 1190 | Disease-modifying anti-rheumatic drugs | - | - | - | - | [1] 46 46 💬
|
| 1191 | Disease-modifying antirheumatic drug | - | - | - | - | [1] 46 46 💬
|
| 1192 | Disease-modifying antirheumatic drugs (DMARDs) | - | - | - | - | [1] 46 46 💬
|
| 1193 | Disease-Modifying Therapies (DMTs) | - | - | - | - | [1] 13 13 💬
|
| 1194 | Disodium citrate | - | - | - | - | [1] 245 245 💬
|
| 1195 | Disodium cromoglycate (DSCG) | - | - | - | - | [1] 85 85 💬
|
| 1196 | Disodium Cromoglycate [cromolyn sodium] | - | - | - | - | [1] 85 85 💬
|
| 1197 | Disodium Pamidronate 15mg (15mg strength) | - | - | - | - | [1] 274 274 💬
|
| 1198 | Disodium Pyrophosphate | - | - | - | - | [1] 166 166 💬
|
| 1199 | Disodiumpyrophosphate | - | - | - | - | [1] 166 166 💬
|
| 1200 | Disulfiram | [1] Disulfiram Disulfiram | [1] Disulfiram
Disulfiram
💬
| [3] ALDH1B1 ALDH1B1, ALDH2, ALDH3A2 💬
| [13] Alcoholic liver disease Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [3] 46 46, 90, 301 💬
|
| 1201 | Disulfiram (DSF) | [1] Disulfiram Disulfiram | [1] Disulfiram
Disulfiram
💬
| [3] ALDH1B1 ALDH1B1, ALDH2, ALDH3A2 💬
| [13] Alcoholic liver disease Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 46 46 💬
|
| 1202 | Ditropan elixir | - | - | - | - | [1] 6 6 💬
|
| 1203 | Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias) | [1] Amiodarone Amiodarone | [2] Amiodarone hydrochloride
Amiodarone hydrochloride
,
Amiodarone
💬
| [17] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [36] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Hormone signaling, IgSF CAM signaling, Insulin secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 28 28 💬
|
| 1204 | Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus EGCG | [1] Amiodarone Amiodarone | [2] Amiodarone hydrochloride
Amiodarone hydrochloride
,
Amiodarone
💬
| [17] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [36] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Hormone signaling, IgSF CAM signaling, Insulin secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 28 28 💬
|
| 1205 | Diuretics, ACEIs/ARBs, beta blockers, positive inotropic drugs, MRAs, SGLT2i, retinoids | - | - | - | - | [3] 57 57, 58, 59 💬
|
| 1206 | DIURF-006 | - | - | - | - | [1] 81 81 💬
|
| 1207 | Divalproex | - | - | - | - | [1] 8 8 💬
|
| 1208 | Divalproex sodium | [1] Valproic acid Valproic acid | [3] Divalproex sodium
Divalproex sodium
,
Valproic acid
,
Valproate sodium
💬
| [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬
| [16] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 51 51 💬
|
| 1209 | Divozilimab | [1] Divozilimab Divozilimab | [1] Divozilimab
Divozilimab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 13 13, 49, 51 💬
|
| 1210 | Dl-3-n-butylphthalide (NBP) | [1] Butylphthalide Butylphthalide | - | - | - | [1] 22 22 💬
|
| 1211 | DLX105 | - | - | - | - | [1] 96 96 💬
|
| 1212 | DM-1992 | - | - | - | - | [1] 6 6 💬
|
| 1213 | DMARD | - | - | - | - | [1] 46 46 💬
|
| 1214 | DMARD cessation | - | - | - | - | [1] 46 46 💬
|
| 1215 | DMARD maintenance | - | - | - | - | [1] 46 46 💬
|
| 1216 | DMARD Therapy | - | - | - | - | [1] 46 46 💬
|
| 1217 | DMARDS | - | - | - | - | [2] 46 46, 271 💬
|
| 1218 | DMARDs (disease-modifying antirheumatic drugs) | - | - | - | - | [1] 46 46 💬
|
| 1219 | DMARDs (methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 46 46 💬
|
| 1220 | DMARDs or Biologics | - | - | - | - | [1] 46 46 💬
|
| 1221 | DMPS | - | - | - | - | [1] 171 171 💬
|
| 1222 | DMSA | - | - | - | - | [1] 171 171 💬
|
| 1223 | DMSO | - | - | - | - | [1] 226 226 💬
|
| 1224 | DMSO cocktail | - | - | - | - | [1] 226 226 💬
|
| 1225 | DMT | - | - | - | - | [1] 13 13 💬
|
| 1226 | DMT continuation | - | - | - | - | [1] 13 13 💬
|
| 1227 | DMTs | - | - | - | - | [1] 13 13 💬
|
| 1228 | DMTs + taurine | [1] Taurine Taurine | [1] Taurine
Taurine
💬
| - | - | [1] 13 13 💬
|
| 1229 | DMX-200 | - | - | - | - | [1] 222 222 💬
|
| 1230 | DnaJ peptide | - | - | - | - | [1] 46 46 💬
|
| 1231 | DnaJP1 | - | - | - | - | [1] 46 46 💬
|
| 1232 | DNL126 | - | - | - | - | [1] 19 19 💬
|
| 1233 | DNL151 | - | - | - | - | [1] 6 6 💬
|
| 1234 | DNL151, DN0001575, DN1575 | - | - | - | - | [1] 6 6 💬
|
| 1235 | DNL201 | - | - | - | - | [1] 6 6 💬
|
| 1236 | DNL310 | - | - | - | - | [1] 19 19 💬
|
| 1237 | DNL310 Drug Substance | - | - | - | - | [1] 19 19 💬
|
| 1238 | DNL343 | [1] DNL343 DNL343 | - | - | - | [1] 2 2 💬
|
| 1239 | DNL593 | - | - | - | - | [1] 127 127 💬
|
| 1240 | DNL593 Sterile Lyophilisate | - | - | - | - | [1] 127 127 💬
|
| 1241 | DNL747 | - | - | - | - | [1] 2 2 💬
|
| 1242 | DNL952 | - | - | - | - | [1] 256 256 💬
|
| 1243 | DNS-7801 (high dose) | - | - | - | - | [1] 6 6 💬
|
| 1244 | DNS-7801 (low-dose) | - | - | - | - | [1] 6 6 💬
|
| 1245 | Dobutamin | - | - | - | - | [1] 215 215 💬
|
| 1246 | Dobutamine | [1] Dobutamine Dobutamine | [3] Dobutamine hydrochloride
Dobutamine hydrochloride
,
Dobutamine
,
Dobutamine tartrate
💬
| [1] ADRB1 ADRB1 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [5] 28 28, 57, 58, 86, 215 💬
|
| 1247 | Dobutamine test | [1] Dobutamine Dobutamine | [3] Dobutamine hydrochloride
Dobutamine hydrochloride
,
Dobutamine
,
Dobutamine tartrate
💬
| [1] ADRB1 ADRB1 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 1248 | Dobutrex | - | - | - | - | [1] 28 28 💬
|
| 1249 | Docosahexaenoic acid | - | - | - | - | [4] 49 49, 90, 240, 299 💬
|
| 1250 | Docosahexaenoic Acid (DHA) | - | - | - | - | [3] 6 6, 94, 299 💬
|
| 1251 | Docosahexaenoic Acid (DHA) Dietary Supplement | - | - | - | - | [2] 13 13, 301 💬
|
| 1252 | Docosahexaenoic acid administration: 50 mg/kg/day during 12 months | - | - | - | - | [1] 299 299 💬
|
| 1253 | Docosahexanoic Acid Supplement | - | - | - | - | [1] 299 299 💬
|
| 1254 | Dojolvi® | - | - | - | - | [1] 344 344 💬
|
| 1255 | Dolasetron | [1] Dolasetron Dolasetron | [2] Dolasetron mesylate
Dolasetron mesylate
,
Dolasetron
💬
| [5] HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬 | [1] 46 46 💬
|
| 1256 | Dolobid | - | - | - | - | [1] 28 28 💬
|
| 1257 | Dolquine | - | - | - | - | [1] 46 46 💬
|
| 1258 | Dolutegravir | [1] Dolutegravir Dolutegravir | [2] Dolutegravir
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | [3] 2 2, 26, 265 💬
|
| 1259 | Dolutegravir (DTG) | [1] Dolutegravir Dolutegravir | [2] Dolutegravir
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | [1] 26 26 💬
|
| 1260 | Dolutegravir / Lamivudine Oral Tablet | [2] Dolutegravir Dolutegravir, Lamivudine | [3] Lamivudine
Lamivudine
,
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | [1] 265 265 💬
|
| 1261 | Dolutegravir 50 MG | [1] Dolutegravir Dolutegravir | [2] Dolutegravir
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | [1] 265 265 💬
|
| 1262 | Dolutegravir, Abacavir and Lamivudine | [3] Abacavir Abacavir, Dolutegravir, Lamivudine | [5] Lamivudine
Lamivudine
,
Abacavir sulfate
,
Abacavir
,
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | [1] 2 2 💬
|
| 1263 | Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO] | [2] Dolutegravir Dolutegravir, Lamivudine | [3] Lamivudine
Lamivudine
,
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | [1] 265 265 💬
|
| 1264 | Domperidone | [1] Domperidone Domperidone | [2] Domperidone
Domperidone
,
Domperidone maleate
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [5] 6 6, 13, 17, 51, 230 💬
|
| 1265 | Domperidone (drug) | [1] Domperidone Domperidone | [2] Domperidone
Domperidone
,
Domperidone maleate
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1266 | Dompéridone | - | - | - | - | [1] 6 6 💬
|
| 1267 | Donepezil | [1] Donepezil Donepezil | [2] Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [8] 5 5, 6, 13, 46, 124, 127, 156, 206 💬
|
| 1268 | Donepezil (Aricept) | [1] Donepezil Donepezil | [2] Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [1] 6 6 💬
|
| 1269 | Donepezil HCI (drug) | [1] Donepezil Donepezil | [2] Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [1] 13 13 💬
|
| 1270 | Donepezil Hydrochloride | [1] Donepezil Donepezil | [2] Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [3] 6 6, 124, 156 💬
|
| 1271 | Donepezil Sandoz | [1] Donepezil Donepezil | [2] Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [1] 6 6 💬
|
| 1272 | Donidalorsen | [1] Donidalorsen Donidalorsen | [1] Donidalorsen sodium
Donidalorsen sodium
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 1273 | DonidalorsenCAS Number: 2304701-45-7Current Sponsor code: ISIS 721744Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 100mg/mL-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Subcutaneous use | - | - | - | - | [1] 65 65 💬
|
| 1274 | Donor Lymphocyte Infusion | - | - | - | - | [1] 60 60 💬
|
| 1275 | Donor Lymphocyte Infusion (DLI) | - | - | - | - | [1] 60 60 💬
|
| 1276 | Donor lymphocytes | - | - | - | - | [1] 28 28 💬
|
| 1277 | Donor mesenchymal stem cell infusions | - | - | - | - | [1] 36 36 💬
|
| 1278 | Donor mobilized PBSC infusion | - | - | - | - | [3] 60 60, 65, 285 💬
|
| 1279 | Donor peripheral blood stem cells. | - | - | - | - | [1] 65 65 💬
|
| 1280 | Dopacell | - | - | - | - | [1] 6 6 💬
|
| 1281 | DopaFuse Delivery System | - | - | - | - | [1] 6 6 💬
|
| 1282 | Dopamine | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [5] 6 6, 7, 17, 74, 77 💬
|
| 1283 | Dopamine Agent | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1284 | Dopamine agonist treatment | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 74 74 💬
|
| 1285 | Dopamine Agonists | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 74 74 💬
|
| 1286 | Dopamine Agonists (pramipexole, ropirinole) | [2] Dopamine Dopamine, Pramipexole | [4] Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Dopamine hydrochloride
,
Pramipexole
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1287 | Dopaminergic Agonist + Apomorphine | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1288 | Dopaminergic Agonists | - | - | - | - | [1] 6 6 💬
|
| 1289 | Dopaminergic medication | - | - | - | - | [1] 6 6 💬
|
| 1290 | Dopastatin | [1] Dopastatin Dopastatin | - | - | - | [1] 77 77 💬
|
| 1291 | Doppler ultrasound | - | - | - | - | [1] 49 49 💬
|
| 1292 | Doppler ultrasound. | - | - | - | - | [1] 46 46 💬
|
| 1293 | Doptelet 20 mg film-coated tablets | - | - | - | - | [1] 63 63 💬
|
| 1294 | Doravirine | [1] Doravirine Doravirine | [1] Doravirine
Doravirine
💬
| - | - | [1] 265 265 💬
|
| 1295 | Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO] | [4] Doravirine Doravirine, Lamivudine, Tenofovir, Tenofovir disoproxil | [6] Lamivudine
Lamivudine
,
Tenofovir disoproxil fumarate
,
Tenofovir
,
Doravirine
,
Tenofovir disoproxil phosphate
,
Tenofovir disoproxil maleate
💬
| - | - | [1] 265 265 💬
|
| 1296 | DORIBAX | - | - | - | - | [1] 299 299 💬
|
| 1297 | Doripenem | [1] Doripenem Doripenem | [2] Doripenem hydrate
Doripenem hydrate
,
Doripenem
💬
| - | - | [1] 299 299 💬
|
| 1298 | DORIPENEM HYDRATE | [1] Doripenem Doripenem | [2] Doripenem hydrate
Doripenem hydrate
,
Doripenem
💬
| - | - | [1] 299 299 💬
|
| 1299 | Dornase alfa | [1] Dornase alfa Dornase alfa | [1] Dornase alfa
Dornase alfa
💬
| - | - | [2] 53 53, 299 💬
|
| 1300 | Dornase alfa (Pulmozyme) | [1] Dornase alfa Dornase alfa | [1] Dornase alfa
Dornase alfa
💬
| - | - | [1] 299 299 💬
|
| 1301 | Dornase alfa [Pulmozyme®] | [1] Dornase alfa Dornase alfa | [1] Dornase alfa
Dornase alfa
💬
| - | - | [1] 299 299 💬
|
| 1302 | Dornase alpha | - | - | - | - | [1] 299 299 💬
|
| 1303 | Dorzagliatin | [1] Dorzagliatin Dorzagliatin | [1] Dorzagliatin
Dorzagliatin
💬
| [1] GCK GCK 💬
| [12] Amino sugar and nucleotide sugar metabolism Amino sugar and nucleotide sugar metabolism, Central carbon metabolism in cancer, Galactose metabolism, Glucagon signaling pathway, Glycolysis / Gluconeogenesis, Insulin secretion, Insulin signaling pathway, Maturity onset diabetes of the young, Neomycin, kanamycin and gentamicin biosynthesis, Prolactin signaling pathway, Starch and sucrose metabolism, Type II diabetes mellitus 💬 | [1] 299 299 💬
|
| 1304 | Dorzolamide | [1] Dorzolamide Dorzolamide | [2] Dorzolamide hydrochloride
Dorzolamide hydrochloride
,
Dorzolamide
💬
| [13] CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬
| [6] Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | [1] 90 90 💬
|
| 1305 | Dosage of cytokines | - | - | - | - | [1] 50 50 💬
|
| 1306 | Dose | - | - | - | - | [1] 98 98 💬
|
| 1307 | Dose A KER-012 | - | - | - | - | [1] 86 86 💬
|
| 1308 | Dose B KER-012 | - | - | - | - | [1] 86 86 💬
|
| 1309 | Dose C KER-012 | - | - | - | - | [1] 86 86 💬
|
| 1310 | Dose level 1 | - | - | - | - | [1] 46 46 💬
|
| 1311 | Dose level 1 group | - | - | - | - | [1] 11 11 💬
|
| 1312 | Dose level 2 | - | - | - | - | [1] 46 46 💬
|
| 1313 | Dose level 2 group | - | - | - | - | [1] 11 11 💬
|
| 1314 | Dose level 3 | - | - | - | - | [1] 46 46 💬
|
| 1315 | Dose level 3 group | - | - | - | - | [1] 11 11 💬
|
| 1316 | Dose level 4 | - | - | - | - | [1] 46 46 💬
|
| 1317 | Dose level 4 group | - | - | - | - | [1] 11 11 💬
|
| 1318 | Dose of 60 mg/kg alpha1-proteinase inhibitor | - | - | - | - | [1] 231 231 💬
|
| 1319 | Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor | - | - | - | - | [1] 231 231 💬
|
| 1320 | Dose-attenuated IST and Hetrombopag | [1] Hetrombopag Hetrombopag | - | - | - | [1] 60 60 💬
|
| 1321 | Dosing Extension | - | - | - | - | [1] 113 113 💬
|
| 1322 | Dosing Interruption of Natalizumab | [1] Natalizumab Natalizumab | [1] Natalizumab
Natalizumab
💬
| [1] ITGA4 ITGA4 💬
| [17] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 💬
|
| 1323 | DOSTINEX | - | - | - | - | [2] 75 75, 77 💬
|
| 1324 | Dostinex 0,5 mg Tabletten | - | - | - | - | [1] 77 77 💬
|
| 1325 | Dostinex 0.5mg tabletts | - | - | - | - | [1] 77 77 💬
|
| 1326 | DOSTINEX 2CPR 0,5MG | - | - | - | - | [1] 77 77 💬
|
| 1327 | DOTANOC | - | - | - | - | [1] 84 84 💬
|
| 1328 | Dotarem 0,5mmol/ml, | - | - | - | - | [1] 13 13 💬
|
| 1329 | Dotatate | [1] Dotatate Dotatate | - | - | - | [5] 19 19, 41, 75, 84, 238 💬
|
| 1330 | Double Dose | - | - | - | - | [2] 38 38, 162 💬
|
| 1331 | Double-blind Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 1332 | Double-blind adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 107 💬
|
| 1333 | Double-Blind Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 51 51 💬
|
| 1334 | Doxazosin | [1] Doxazosin Doxazosin | [2] Doxazosin mesylate
Doxazosin mesylate
,
Doxazosin
💬
| [3] ADRA1A ADRA1A, ADRA1B, ADRA1D 💬
| [9] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 57 57, 67 💬
|
| 1335 | Doxepin | [1] Doxepin Doxepin | [2] Doxepin hydrochloride
Doxepin hydrochloride
,
Doxepin
💬
| [3] HRH1 HRH1, SLC6A2, SLC6A4 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 6 6 💬
|
| 1336 | Doxepin and Zopiclone | [2] Doxepin Doxepin, Zopiclone | [3] Doxepin hydrochloride
Doxepin hydrochloride
,
Zopiclone
,
Doxepin
💬
| [19] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, SLC6A2, SLC6A4 💬
| [12] Cadherin signaling Cadherin signaling, Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction 💬 | [1] 6 6 💬
|
| 1337 | DOXICICLINA | - | - | - | - | [1] 28 28 💬
|
| 1338 | Doxil | - | - | - | - | [1] 63 63 💬
|
| 1339 | Doxorubicin | [1] Doxorubicin Doxorubicin | [2] Doxorubicin hydrochloride
Doxorubicin hydrochloride
,
Doxorubicin
💬
| - | - | [6] 26 26, 28, 34, 65, 299, 331 💬
|
| 1340 | Doxorubicin Hydrochloride | [1] Doxorubicin Doxorubicin | [2] Doxorubicin hydrochloride
Doxorubicin hydrochloride
,
Doxorubicin
💬
| - | - | [3] 26 26, 34, 331 💬
|
| 1341 | Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase | [3] Cyclophosphamide Cyclophosphamide, Doxorubicin, Methotrexate | [6] Methotrexate
Methotrexate
,
Cyclophosphamide
,
Doxorubicin hydrochloride
,
Methotrexate sodium
,
Doxorubicin
,
Cyclophosphamide
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 65 65 💬
|
| 1342 | Doxycyclin | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 299 299 💬
|
| 1343 | Doxycycline | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [17] 13 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 💬
|
| 1344 | Doxycycline 100 mg Capsules | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 89 89 💬
|
| 1345 | Doxycycline 100-200mg capsules daily for 6 months | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 167 167 💬
|
| 1346 | DOXYCYCLINE HYCLATE | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [3] 23 23, 96, 227 💬
|
| 1347 | Doxycycline Hyclate Ph.Eur | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 167 167 💬
|
| 1348 | Doxycycline Injection [Doxy] | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 34 34 💬
|
| 1349 | Doxycycline Tablets | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 46 46 💬
|
| 1350 | DoxyHEXAL® tabs 100 mg Tabletten | - | - | - | - | [1] 28 28 💬
|
| 1351 | DP Mannitol | [1] Mannitol Mannitol | [1] Mannitol
Mannitol
💬
| - | - | [1] 299 299 💬
|
| 1352 | DPA-714 Metabolite Analysis | - | - | - | - | [1] 6 6 💬
|
| 1353 | DPA-714 PET/MRI | - | - | - | - | [1] 13 13 💬
|
| 1354 | DPA-714-PET/MRI | - | - | - | - | [1] 6 6 💬
|
| 1355 | DPPG | - | - | - | - | [1] 79 79 💬
|
| 1356 | DPPSA771-1/1 (part of BX004-A combination) | - | - | - | - | [1] 299 299 💬
|
| 1357 | DPPSA771-2/1 (part of BX004-A combination) | - | - | - | - | [1] 299 299 💬
|
| 1358 | DPPSA908-1/1 (part of BX004-A combination) | - | - | - | - | [1] 299 299 💬
|
| 1359 | Dr. Reddy’s Rituximab (DRL_RI) 100mg | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 1360 | Dr. Reddy’s Rituximab (DRL_RI) 500mg | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 1361 | Dratumumab / Hyaluronidase Injection [Darzalex Faspro] | [1] Hyaluronidase Hyaluronidase | [3] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬
| - | - | [1] 28 28 💬
|
| 1362 | DRF | - | - | - | - | [1] 13 13 💬
|
| 1363 | Dried blood spot (DBS) sampling | - | - | - | - | [1] 19 19 💬
|
| 1364 | Dried Blood Spot device | - | - | - | - | [1] 46 46 💬
|
| 1365 | Dried Chicory Root | - | - | - | - | [1] 97 97 💬
|
| 1366 | Drisapersen | [1] Drisapersen Drisapersen | [1] Drisapersen
Drisapersen
💬
| [1] DMD DMD 💬
| [5] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | [1] 113 113 💬
|
| 1367 | DRISAPERSEN SODIUM | [1] Drisapersen Drisapersen | [1] Drisapersen
Drisapersen
💬
| [1] DMD DMD 💬
| [5] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | [1] 113 113 💬
|
| 1368 | DRL_RI | - | - | - | - | [1] 46 46 💬
|
| 1369 | Dronabinol | [1] Dronabinol Dronabinol | [1] Dronabinol
Dronabinol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [5] 2 2, 13, 46, 271, 298 💬
|
| 1370 | Dronabinol 25 mg/ml, oral drops | [1] Dronabinol Dronabinol | [1] Dronabinol
Dronabinol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬
|
| 1371 | Dronabinol capsule 2,5 mg | [1] Dronabinol Dronabinol | [1] Dronabinol
Dronabinol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬
|
| 1372 | Dronabinol capsule 2.5. mg | [1] Dronabinol Dronabinol | [1] Dronabinol
Dronabinol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [2] 46 46, 271 💬
|
| 1373 | Drops | - | - | - | - | [2] 50 50, 107 💬
|
| 1374 | Drospirenone | [1] Drospirenone Drospirenone | [1] Drospirenone
Drospirenone
💬
| [2] NR3C2 NR3C2, PGR 💬
| [6] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [1] 118 118 💬
|
| 1375 | Drospirenone/Ethinylestradiol (Yaz) | [2] Drospirenone Drospirenone, Ethinylestradiol | [2] Ethinyl estradiol
Ethinyl estradiol
,
Drospirenone
💬
| [3] ESR1 ESR1, NR3C2, PGR 💬
| [12] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 118 118 💬
|
| 1376 | Drospirenone/Ethinylestradiol/Methyltetrahydrofolate | [2] Drospirenone Drospirenone, Ethinylestradiol | [2] Ethinyl estradiol
Ethinyl estradiol
,
Drospirenone
💬
| [3] ESR1 ESR1, NR3C2, PGR 💬
| [12] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 118 118 💬
|
| 1377 | Droxidopa | [1] Droxidopa Droxidopa | [1] Droxidopa
Droxidopa
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [5] 5 5, 6, 17, 169, 170 💬
|
| 1378 | Droxidopa 100 MG [Northera] | [1] Droxidopa Droxidopa | [1] Droxidopa
Droxidopa
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 1379 | Droxidopa Oral Product | [1] Droxidopa Droxidopa | [1] Droxidopa
Droxidopa
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 169 169 💬
|
| 1380 | DRSP/EE | - | - | - | - | [1] 67 67 💬
|
| 1381 | Drug - SHR1459 | - | - | - | - | [1] 13 13 💬
|
| 1382 | Drug free, IS monotherapy and GC combined with IS | - | - | - | - | [1] 300 300 💬
|
| 1383 | Drug inducing antiphospholipid syndrome | - | - | - | - | [1] 48 48 💬
|
| 1384 | Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom | - | - | - | - | [2] 46 46, 49 💬
|
| 1385 | Drug protocol | - | - | - | - | [1] 46 46 💬
|
| 1386 | Drug treatment | - | - | - | - | [5] 46 46, 50, 51, 74, 271 💬
|
| 1387 | Drug-Carbamazepine (Tegretol XR) | [1] Carbamazepine Carbamazepine | [1] Carbamazepine
Carbamazepine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 231 231 💬
|
| 1388 | Drug: Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 1389 | Drug: Atrasentan | [1] Atrasentan Atrasentan | [1] Atrasentan hydrochloride
Atrasentan hydrochloride
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 1390 | Drug: Bionetide | - | - | - | - | [1] 156 156 💬
|
| 1391 | Drug: F 18 T807 | - | - | - | - | [1] 2 2 💬
|
| 1392 | Drug: KVD900 300 mg | - | - | - | - | [1] 65 65 💬
|
| 1393 | Drug: LW402 | - | - | - | - | [1] 46 46 💬
|
| 1394 | Drug: Salirumab | - | - | - | - | [1] 46 46 💬
|
| 1395 | Drug: Tocilizmab | - | - | - | - | [1] 46 46 💬
|
| 1396 | Drug: Topical Rapamycin | - | - | - | - | [1] 157 157 💬
|
| 1397 | DRX005B | - | - | - | - | [1] 19 19 💬
|
| 1398 | Dry Powder Inhaler | - | - | - | - | [1] 85 85 💬
|
| 1399 | Dry powder tobramycin | [1] Tobramycin Tobramycin | [2] Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | [1] 299 299 💬
|
| 1400 | DS-1211b | - | - | - | - | [1] 166 166 💬
|
| 1401 | DS-2325a | [1] DS-2325a DS-2325a | - | - | - | [1] 160 160 💬
|
| 1402 | DS-5141b | - | - | - | - | [1] 113 113 💬
|
| 1403 | DS-7011a | - | - | - | - | [1] 49 49 💬
|
| 1404 | DSG3-CAART | - | - | - | - | [1] 35 35 💬
|
| 1405 | DSP-3077 Retinal Sheet Cohort 1 | - | - | - | - | [1] 90 90 💬
|
| 1406 | DSP-3077 Retinal Sheet Cohort 2 | - | - | - | - | [1] 90 90 💬
|
| 1407 | DSP-3077 Retinal Sheet Cohort 3 | - | - | - | - | [1] 90 90 💬
|
| 1408 | DSP-9632P 27.5 mg | - | - | - | - | [1] 6 6 💬
|
| 1409 | DSP-9632P 55.0 mg | - | - | - | - | [1] 6 6 💬
|
| 1410 | DSP-9632P 82.5 mg | - | - | - | - | [1] 6 6 💬
|
| 1411 | DT-216 | - | - | - | - | [1] 18 18 💬
|
| 1412 | DT-216P2 | - | - | - | - | [1] 18 18 💬
|
| 1413 | DT-DEC01 | [1] DT-DEC01 DT-DEC01 | - | - | - | [1] 113 113 💬
|
| 1414 | DT-DEC01 (MB^N/MB^DMD DEC) | [1] DT-DEC01 DT-DEC01 | - | - | - | [1] 113 113 💬
|
| 1415 | DTR Melatonin (NIH CC PDS) | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬
| [2] MTNR1A MTNR1A, MTNR1B 💬
| [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 202 202 💬
|
| 1416 | DTX301 | [1] Avalotcagene ontaparvovec Avalotcagene ontaparvovec | - | - | - | [1] 251 251 💬
|
| 1417 | Dual AAV8.MYO7A | - | - | - | - | [2] 90 90, 303 💬
|
| 1418 | Dual antiplatelet therapy | - | - | - | - | [1] 48 48 💬
|
| 1419 | Dual biological therapy | - | - | - | - | [1] 97 97 💬
|
| 1420 | Dual Energy X-ray Absorptiometry (DEXA) | - | - | - | - | [1] 299 299 💬
|
| 1421 | Dual release hydrocortisone (plenadren) | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 1422 | Dual-therapy | - | - | - | - | [1] 50 50 💬
|
| 1423 | Ducressa | - | - | - | - | [1] 90 90 💬
|
| 1424 | Dulaglutide | [1] Dulaglutide Dulaglutide | [1] Dulaglutide
Dulaglutide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1425 | Dulaglutide 0.75Mg/0.5Ml Inj Pen | [1] Dulaglutide Dulaglutide | [1] Dulaglutide
Dulaglutide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 1426 | Duloxetine | [1] Duloxetine Duloxetine | [2] Duloxetine hydrochloride
Duloxetine hydrochloride
,
Duloxetine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [3] 6 6, 13, 97 💬
|
| 1427 | Duloxetine hydrochloride | [1] Duloxetine Duloxetine | [2] Duloxetine hydrochloride
Duloxetine hydrochloride
,
Duloxetine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 6 6 💬
|
| 1428 | Duloxetine Hydrochloride (HCI) | [1] Duloxetine Duloxetine | [2] Duloxetine hydrochloride
Duloxetine hydrochloride
,
Duloxetine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 13 13 💬
|
| 1429 | Duo-Therapy with Sildenafil + Bosentan | [2] Bosentan Bosentan, Sildenafil | [4] Bosentan
Bosentan
,
Sildenafil citrate
,
Bosentan
,
Sildenafil
💬
| [3] EDNRA EDNRA, EDNRB, PDE5A 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 1430 | DUOC-01 | - | - | - | - | [3] 13 13, 19, 20 💬
|
| 1431 | DUODOPA | - | - | - | - | [1] 6 6 💬
|
| 1432 | Duodopa gel intestinale | - | - | - | - | [1] 6 6 💬
|
| 1433 | Duodopa intestinal gel | - | - | - | - | [1] 6 6 💬
|
| 1434 | Duodopa intestinalgel | - | - | - | - | [1] 6 6 💬
|
| 1435 | Duodopa LD/CD 20/5 mg/mL | - | - | - | - | [1] 6 6 💬
|
| 1436 | Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel | - | - | - | - | [1] 6 6 💬
|
| 1437 | Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1438 | DUODOPA®Intestinal Gel | - | - | - | - | [1] 6 6 💬
|
| 1439 | Dupilumab | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [8] 51 51, 97, 98, 160, 162, 222, 300, 306 💬
|
| 1440 | Dupilumab (blinded) | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 98 98 💬
|
| 1441 | Dupilumab (open-label) | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 98 98 💬
|
| 1442 | Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT] | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 98 98 💬
|
| 1443 | Dupilumab 300Mg Solution for Injection | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 51 51 💬
|
| 1444 | Dupilumab Injection | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 160 160 💬
|
| 1445 | Dupilumab open label extension phase | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 222 222 💬
|
| 1446 | Dupilumab Prefilled Syringe | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 160 160 💬
|
| 1447 | Dupixent | - | - | - | - | [3] 98 98, 160, 162 💬
|
| 1448 | DUR-928 | - | - | - | - | [1] 94 94 💬
|
| 1449 | DURAMYCIN | - | - | - | - | [1] 299 299 💬
|
| 1450 | Duramycin, 2622U90 | - | - | - | - | [1] 299 299 💬
|
| 1451 | Durlobactam | [1] Durlobactam Durlobactam | [2] Durlobactam
Durlobactam
,
Durlobactam sodium
💬
| - | - | [1] 299 299 💬
|
| 1452 | Durvalumab | [1] Durvalumab Durvalumab | [1] Durvalumab
Durvalumab
💬
| [1] CD274 CD274 💬
| [2] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | [1] 85 85 💬
|
| 1453 | Dusquetide | [1] Dusquetide Dusquetide | [1] Dusquetide
Dusquetide
💬
| - | - | [1] 56 56 💬
|
| 1454 | Dutasterida | [1] Dutasteride Dutasteride | [1] Dutasteride
Dutasteride
💬
| [2] SRD5A1 SRD5A1, SRD5A2 💬
| [2] Prostate cancer Prostate cancer, Steroid hormone biosynthesis 💬 | [1] 2 2 💬
|
| 1455 | Dutasteride | [1] Dutasteride Dutasteride | [1] Dutasteride
Dutasteride
💬
| [2] SRD5A1 SRD5A1, SRD5A2 💬
| [2] Prostate cancer Prostate cancer, Steroid hormone biosynthesis 💬 | [2] 1 1, 2 💬
|
| 1456 | Duvakitug | [1] Duvakitug Duvakitug | [1] Duvakitug
Duvakitug
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [2] 96 96, 97 💬
|
| 1457 | Duvoglustat | [1] Duvoglustat Duvoglustat | [2] Duvoglustat
Duvoglustat
,
Duvoglustat hydrochloride
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 1458 | Duvoglustat HCl | [1] Duvoglustat Duvoglustat | [2] Duvoglustat
Duvoglustat
,
Duvoglustat hydrochloride
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 1459 | Duvoglustat hydrochloride | [1] Duvoglustat Duvoglustat | [2] Duvoglustat
Duvoglustat
,
Duvoglustat hydrochloride
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 1460 | DW1809 | - | - | - | - | [1] 46 46 💬
|
| 1461 | DW1809-1 | - | - | - | - | [1] 46 46 💬
|
| 1462 | DW1809-T2 | - | - | - | - | [1] 46 46 💬
|
| 1463 | DWN12088 | - | - | - | - | [1] 85 85 💬
|
| 1464 | DWP422 25mg | - | - | - | - | [1] 46 46 💬
|
| 1465 | DX-2930 | - | - | - | - | [1] 65 65 💬
|
| 1466 | DX-2930 - 150mg/4wk | - | - | - | - | [1] 65 65 💬
|
| 1467 | DX-2930 - 300mg/2wk | - | - | - | - | [1] 65 65 💬
|
| 1468 | DX-2930 - 300mg/4wk | - | - | - | - | [1] 65 65 💬
|
| 1469 | DX-88 | - | - | - | - | [1] 65 65 💬
|
| 1470 | DX-88 (ecallantide) | [1] Ecallantide Ecallantide | [1] Ecallantide
Ecallantide
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 1471 | DX-88 ecallantide | [1] Ecallantide Ecallantide | [1] Ecallantide
Ecallantide
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 1472 | DX-890 | [1] Depelestat Depelestat | [1] Depelestat
Depelestat
💬
| [1] ELANE ELANE 💬
| [4] Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Phagocytosis, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬 | [1] 299 299 💬
|
| 1473 | DX2930 | - | - | - | - | [1] 65 65 💬
|
| 1474 | DYDROGESTERONE | [1] Dydrogesterone Dydrogesterone | [1] Dydrogesterone
Dydrogesterone
💬
| [1] PGR PGR 💬
| [5] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [1] 13 13 💬
|
| 1475 | DYN101 | [1] DYN-101 DYN-101 | - | - | - | [1] 111 111 💬
|
| 1476 | Dynacirc CR (Isradipine) | [1] Isradipine Isradipine | [1] Isradipine
Isradipine
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 1477 | Dynamic Contrast-Enhanced Magnetic Resonance Imaging | - | - | - | - | [1] 13 13 💬
|
| 1478 | DYNE-101 | - | - | - | - | [1] 113 113 💬
|
| 1479 | DYNE-251 | [1] DYNE-251 DYNE-251 | - | - | - | [1] 113 113 💬
|
| 1480 | Dyphenhydramine hydrochloride | - | - | - | - | [1] 63 63 💬
|
| 1481 | Dysport | - | - | - | - | [2] 13 13, 36 💬
|
| 1482 | DYSPORT*SC IM 2FL 500U | - | - | - | - | [1] 13 13 💬
|
| 1483 | DYSPORT® | - | - | - | - | [1] 13 13 💬
|
| 1484 | Dysport® (Botulinumtoxin A (Btx A)) | - | - | - | - | [1] 36 36 💬
|
| 1485 | DZD8586 dose level 1 | - | - | - | - | [1] 63 63 💬
|
| 1486 | DZD8586 dose level 2 | - | - | - | - | [1] 63 63 💬
|
| 1487 | DZD8586 dose level 3 | - | - | - | - | [1] 63 63 💬
|
| 1488 | DZP | - | - | - | - | [1] 49 49 💬
|
| 1489 | Désogestrel | - | - | - | - | [1] 230 230 💬
|